CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | hemiaminal |
|
Accession: | CHEBI:73080
|
browse the term
|
Definition: | Any organic amino compound that has an amino group and a hydroxy group attached to the same carbon atom. Hemiaminals are intermediates in the formation of imines by addition of an amine to an aldehyde or ketone; those derived from primary amines are particularly unstable. |
Synonyms: | related_synonym: | Formula=CHNOR4; SMILES=OC([*])([*])N([*])[*]; carbinolamine; carbinolamines; hemiaminals |
| xref: | Wikipedia:Hemiaminal |
|
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Ajmaline inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein] |
CTD |
PMID:29782822 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Ajmaline results in decreased activity of KCNH2 protein |
CTD |
PMID:15599706 PMID:24052561 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Scn5a |
sodium voltage-gated channel alpha subunit 5 |
decreases activity affects response to substance |
ISO |
Ajmaline results in decreased activity of SCN5A protein SCN5A protein affects the susceptibility to Ajmaline |
CTD |
PMID:10662748 PMID:15520322 PMID:20174578 |
|
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
|
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
climbazole results in increased expression of CYP2B1 mRNA; climbazole results in increased expression of CYP2B1 protein |
CTD |
PMID:11552297 PMID:11824557 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
EXP |
climbazole results in increased expression of CYP3A2 protein |
CTD |
PMID:11552297 PMID:11824557 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
increases expression |
EXP |
climbazole results in increased expression of CYP4A1 protein |
CTD |
PMID:11552297 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases activity |
ISO |
cloxazolam results in decreased activity of AKR1C1 protein |
CTD |
PMID:12604236 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases activity |
ISO |
cloxazolam results in decreased activity of AKR1C2 protein |
CTD |
PMID:12604236 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
cloxazolam results in decreased activity of AKR1C3 protein |
CTD |
PMID:11995921 PMID:12604236 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Capsaicin results in increased expression of ABCA1 protein] |
CTD |
PMID:21908651 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity |
ISO |
KT 5720 results in decreased activity of ABCB1 protein |
CTD |
PMID:15725475 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO EXP |
KT 5720 inhibits the reaction [Bucladesine affects the localization of ABCC2 protein]; KT 5720 inhibits the reaction [Bucladesine results in increased expression of ABCC2 mRNA]; KT 5720 inhibits the reaction [Bucladesine results in increased expression of ABCC2 protein] KT 5720 inhibits the reaction [Bucladesine affects the localization of ABCC2 protein]; KT 5720 inhibits the reaction [Taurolithocholic Acid results in decreased activity of and affects the localization of ABCC2 protein] |
CTD |
PMID:26049102 PMID:29052767 PMID:31300867 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [[Phenylephrine results in increased activity of ADRA1A protein] which results in decreased transport of Potassium] |
CTD |
PMID:15365637 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [Taurolithocholic Acid results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:31300867 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]] |
CTD |
PMID:24254769 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Bucladesine results in increased expression of ATF2 protein modified form] |
CTD |
PMID:26049102 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [NPPA protein results in increased secretion of CALCA protein] |
CTD |
PMID:17522345 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Cartpt |
CART prepropeptide |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] |
CTD |
PMID:19632277 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
KT 5720 inhibits the reaction [cilostazol results in increased activity of CASP3 protein]; KT 5720 inhibits the reaction [Colforsin results in increased activity of CASP3 protein] KT 5720 inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP3 protein] KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein] |
CTD |
PMID:20131233 PMID:21873648 PMID:32115946 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
multiple interactions |
ISO |
KT 5720 affects the reaction [muscarinic toxin 7 binds to CHRM1 protein]; KT 5720 promotes the reaction [Acetylcholine binds to CHRM1 protein]; KT 5720 promotes the reaction [N-Methylscopolamine binds to CHRM1 protein]; Staurosporine affects the reaction [KT 5720 promotes the reaction [N-Methylscopolamine binds to CHRM1 protein]] |
CTD |
PMID:10860942 PMID:16439611 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
ISO |
KT 5720 promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] |
CTD |
PMID:10860942 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
affects binding |
EXP |
KT 5720 binds to CHRM3 protein |
CTD |
PMID:12435818 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Isoproterenol results in increased expression of CIDEC protein] |
CTD |
PMID:21097823 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [cilostazol results in increased phosphorylation of CSNK2A1 protein] |
CTD |
PMID:24254769 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [cilostazol affects the expression of EP300 protein] |
CTD |
PMID:24254769 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [Norepinephrine inhibits the reaction [Carbachol results in increased expression of FGF1 protein]] |
CTD |
PMID:15264218 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [[1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone binds to and results in increased activity of GPER1 protein] which results in increased expression of SLC1A2 protein] |
CTD |
PMID:22645130 |
|
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] |
CTD |
PMID:19632277 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA1 mRNA] |
CTD |
PMID:26049102 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA2 mRNA] |
CTD |
PMID:26049102 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA4 mRNA] |
CTD |
PMID:26049102 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
KT 5720 inhibits the reaction [Nitroprusside results in increased expression of HMOX1 protein] Dinoprostone inhibits the reaction [KT 5720 promotes the reaction [Lipopolysaccharides results in increased activity of HMOX1 protein]]; KT 5720 inhibits the reaction [Dinoprostone inhibits the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]]; KT 5720 promotes the reaction [Lipopolysaccharides results in increased activity of HMOX1 protein]; KT 5720 promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein] |
CTD |
PMID:16439612 PMID:24003391 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Dipyridamole promotes the reaction [IL1B protein results in increased abundance of Cyclic AMP]] |
CTD |
PMID:8904084 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [2-(2-fluorobenzamido)benzoate ethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]] |
CTD |
PMID:21457779 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Bucladesine results in increased expression of JUN protein modified form]; KT 5720 inhibits the reaction [Bucladesine results in increased expression of JUN protein] |
CTD |
PMID:26049102 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Capsaicin results in decreased expression of LRP1 protein] |
CTD |
PMID:21908651 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK1 protein]] |
CTD |
PMID:11675405 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of MAPK3 protein]] |
CTD |
PMID:11675405 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [Mevinphos results in increased expression of NOS1 protein] |
CTD |
PMID:17438462 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [NPPA protein results in increased secretion of CALCA protein] |
CTD |
PMID:17522345 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nucb2 |
nucleobindin 2 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [NUCB2 protein results in increased import of Calcium] |
CTD |
PMID:17627999 |
|
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
|
|
G |
Pla2g6 |
phospholipase A2 group VI |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [UCN protein results in decreased expression of PLA2G6 protein] |
CTD |
PMID:17885217 |
|
NCBI chr 7:110,851,378...110,891,557
Ensembl chr 7:110,851,378...110,891,114
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [Bucladesine results in increased activity of PRKACA protein]; KT 5720 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] |
CTD |
PMID:31300867 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[KT 5720 co-treated with Dinoprostone] inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; KT 5720 affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:24003391 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]]; KT 5720 inhibits the reaction [cilostazol results in increased phosphorylation of SIRT1 protein] |
CTD |
PMID:24254769 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [[1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone binds to and results in increased activity of GPER1 protein] which results in increased expression of SLC1A2 protein] |
CTD |
PMID:22645130 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [isoeugenol results in increased expression of SOCS3 mRNA] |
CTD |
PMID:21969073 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Th |
tyrosine hydroxylase |
decreases expression multiple interactions |
EXP |
KT 5720 results in decreased expression of TH mRNA KT 5720 inhibits the reaction [Colforsin results in increased expression of TH mRNA]; KT 5720 inhibits the reaction [HU 211 results in decreased expression of TH mRNA] |
CTD |
PMID:18992715 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [Terbutaline inhibits the reaction [Shiga Toxin results in increased expression of TNF mRNA]]; KT 5720 inhibits the reaction [Terbutaline results in decreased expression of TNF mRNA] |
CTD |
PMID:11675405 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [modafinil results in increased expression of TNFSF11 mRNA] |
CTD |
PMID:29649498 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Ucn |
urocortin |
multiple interactions |
EXP |
KT 5720 inhibits the reaction [UCN protein results in decreased expression of PLA2G6 protein] |
CTD |
PMID:17885217 |
|
NCBI chr 6:25,238,120...25,238,950
Ensembl chr 6:25,238,120...25,238,950
|
|
G |
Zfp36 |
zinc finger protein 36 |
multiple interactions |
ISO |
KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein] |
CTD |
PMID:21969073 |
|
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
|
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Ginkgo biloba extract inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]]; KT 5823 inhibits the reaction [ginkgolide C inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]]; KT 5823 inhibits the reaction [Quercetin inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]] |
CTD |
PMID:18001288 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arhgef17 |
Rho guanine nucleotide exchange factor 17 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP promotes the reaction [PRKG1 protein binds to and results in increased phosphorylation of ARHGEF17 protein]] |
CTD |
PMID:23195829 |
|
NCBI chr 1:155,230,607...155,290,163
Ensembl chr 1:155,233,168...155,290,498
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP ISO |
KT 5823 inhibits the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid] KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of BDNF protein]] |
CTD |
PMID:19428112 PMID:22850435 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [8-bromocyclic GMP inhibits the reaction [TNF protein results in increased activity of CASP3 protein]] |
CTD |
PMID:9388267 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
multiple interactions |
ISO |
KT 5823 promotes the reaction [N-Methylscopolamine binds to CHRM1 protein] |
CTD |
PMID:10860942 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
ISO |
KT 5823 promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] |
CTD |
PMID:10860942 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Ginkgo biloba extract inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]]; KT 5823 inhibits the reaction [ginkgolide C inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]]; KT 5823 inhibits the reaction [Quercetin inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]] |
CTD |
PMID:18001288 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]] |
CTD |
PMID:22850435 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
KT 5823 inhibits the reaction [EDN1 protein results in decreased secretion of Norepinephrine]; KT 5823 promotes the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]; KT 5823 promotes the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:12184995 PMID:16389725 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Edn3 |
endothelin 3 |
multiple interactions |
EXP |
KT 5823 inhibits the reaction [EDN3 protein results in decreased secretion of Norepinephrine] |
CTD |
PMID:12184995 |
|
NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [bisphenol A promotes the reaction [FOS protein binds to GPER1 promoter]] |
CTD |
PMID:23274518 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
multiple interactions |
EXP |
KT 5823 inhibits the reaction [manganese chloride results in increased secretion of GNRH1 protein] |
CTD |
PMID:17110411 PMID:17290048 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [bisphenol A promotes the reaction [FOS protein binds to GPER1 promoter]]; KT 5823 inhibits the reaction [bisphenol A results in increased expression of GPER1 mRNA]; KT 5823 inhibits the reaction [bisphenol A results in increased expression of GPER1 protein] |
CTD |
PMID:23274518 |
|
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases activity |
ISO |
KT 5823 results in decreased activity of GSK3B protein |
CTD |
PMID:12534346 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Dipyridamole promotes the reaction [IL1B protein results in increased abundance of Cyclic AMP]] |
CTD |
PMID:8904084 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL6 protein] |
CTD |
PMID:35122928 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP ISO |
KT 5823 promotes the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein] KT 5823 affects the reaction [heat stable toxin (E coli) results in decreased phosphorylation of MAPK1 protein]; KT 5823 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein] KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]] |
CTD |
PMID:16389725 PMID:17828804 PMID:22850435 PMID:35122928 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP ISO |
KT 5823 promotes the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein] KT 5823 affects the reaction [heat stable toxin (E coli) results in decreased phosphorylation of MAPK3 protein]; KT 5823 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK3 protein] KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:16389725 PMID:17828804 PMID:22850435 PMID:35122928 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:35122928 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:35122928 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapkapk5 |
MAPK activated protein kinase 5 |
decreases activity |
ISO |
KT 5823 results in decreased activity of MAPKAPK5 protein |
CTD |
PMID:12534346 |
|
NCBI chr12:34,993,520...35,013,059
Ensembl chr12:34,994,092...35,013,052
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
KT 5823 affects the reaction [heat stable toxin (E coli) results in decreased phosphorylation of MYC protein] |
CTD |
PMID:17828804 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA]; KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] |
CTD |
PMID:27774770 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:35122928 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Plat |
plasminogen activator, tissue type |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Dipyridamole results in increased secretion of PLAT protein] |
CTD |
PMID:15733978 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP promotes the reaction [PRKG1 protein binds to and results in increased phosphorylation of ARHGEF17 protein]]; KT 5823 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of RHOA protein] |
CTD |
PMID:23195829 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RELA protein] |
CTD |
PMID:35122928 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of RHOA protein] |
CTD |
PMID:23195829 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
EXP |
KT 5823 inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [8-bromocyclic GMP inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in increased secretion of SPP1 protein]] |
CTD |
PMID:20453393 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
KT 5823 inhibits the reaction [8-bromocyclic GMP inhibits the reaction [TNF protein results in increased activity of CASP3 protein]] |
CTD |
PMID:9388267 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
ISO EXP |
KT 5823 inhibits the reaction [4-((3,4-(methylenedioxy)benzyl)amino)-6-methoxyquinazoline analog results in increased phosphorylation of TRPC6 protein]; KT 5823 inhibits the reaction [8-bromocyclic GMP results in increased phosphorylation of TRPC6 protein] KT 5823 inhibits the reaction [4-((3,4-(methylenedioxy)benzyl)amino)-6-methoxyquinazoline analog inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein]]; KT 5823 inhibits the reaction [4-((3,4-(methylenedioxy)benzyl)amino)-6-methoxyquinazoline analog results in increased phosphorylation of TRPC6 protein] |
CTD |
PMID:20177073 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
EXP |
KT 5823 inhibits the reaction [Dipyridamole inhibits the reaction [Glucose results in decreased expression of TXN1 protein]] |
CTD |
PMID:20453393 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
multiple interactions |
ISO |
KT 5926 inhibits the reaction [calyculin A results in increased phosphorylation of LCP1 protein]; KT 5926 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of LCP1 protein] |
CTD |
PMID:14769871 |
|
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
solasodine results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:28283413 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity |
ISO |
solasodine results in decreased activity of BCHE protein |
CTD |
PMID:31152736 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bsg |
basigin |
decreases expression |
ISO |
solasodine results in decreased expression of BSG mRNA |
CTD |
PMID:28283413 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
solasodine results in increased cleavage of and results in decreased expression of CASP3 protein |
CTD |
PMID:37121296 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
solasodine results in increased cleavage of and results in decreased expression of CASP7 protein |
CTD |
PMID:37121296 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
solasodine results in increased cleavage of and results in decreased expression of CASP9 protein |
CTD |
PMID:37121296 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions increases expression |
ISO |
CLDN2 protein inhibits the reaction [solasodine results in increased expression of CDH1 protein] |
CTD |
PMID:37121296 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression multiple interactions |
ISO |
solasodine results in decreased expression of CDH2 mRNA; solasodine results in decreased expression of CDH2 protein CLDN2 protein inhibits the reaction [solasodine results in decreased expression of CDH2 protein] |
CTD |
PMID:37121296 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions decreases expression |
ISO |
acadesine promotes the reaction [solasodine results in decreased expression of CLDN2 protein]; CLDN2 protein inhibits the reaction [solasodine results in decreased expression of CDH2 protein]; CLDN2 protein inhibits the reaction [solasodine results in decreased expression of VIM protein]; CLDN2 protein inhibits the reaction [solasodine results in increased expression of CDH1 protein] solasodine results in decreased expression of CLDN2 mRNA; solasodine results in decreased expression of CLDN2 protein |
CTD |
PMID:37121296 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression |
ISO |
solasodine results in decreased expression of GPX4 protein |
CTD |
PMID:37121296 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
solasodine inhibits the reaction [Ovalbumin results in increased secretion of IL1B protein] |
CTD |
PMID:36084726 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
EXP |
solasodine inhibits the reaction [Ovalbumin results in increased secretion of IL4 protein] |
CTD |
PMID:36084726 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
EXP |
solasodine inhibits the reaction [Ovalbumin results in increased secretion of IL5 protein] |
CTD |
PMID:36084726 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Mir21 |
microRNA 21 |
decreases expression |
ISO |
solasodine results in decreased expression of MIR21; solasodine results in decreased expression of MIR21 mRNA |
CTD |
PMID:28283413 PMID:37121296 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
ISO |
solasodine results in decreased expression of MMP2 mRNA |
CTD |
PMID:28283413 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
solasodine results in decreased expression of MMP9 mRNA |
CTD |
PMID:28283413 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
solasodine results in increased cleavage of and results in decreased expression of PARP1 protein |
CTD |
PMID:37121296 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
increases phosphorylation |
ISO |
solasodine results in increased phosphorylation of PRKAA1 protein |
CTD |
PMID:37121296 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
increases expression |
ISO |
solasodine results in increased expression of RECK mRNA |
CTD |
PMID:28283413 |
|
NCBI chr 5:58,102,961...58,169,516
Ensembl chr 5:58,102,981...58,169,502
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases localization |
ISO |
solasodine results in decreased localization of RELA protein |
CTD |
PMID:37121296 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression |
ISO |
solasodine results in decreased expression of RHOA protein |
CTD |
PMID:37121296 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
solasodine results in decreased expression of SLC7A11 protein |
CTD |
PMID:37121296 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases phosphorylation |
ISO |
solasodine results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:37121296 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
solasodine results in increased expression of TIMP1 mRNA |
CTD |
PMID:28283413 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression |
ISO |
solasodine results in increased expression of TIMP2 mRNA |
CTD |
PMID:28283413 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
solasodine inhibits the reaction [Ovalbumin results in increased secretion of TNF protein] |
CTD |
PMID:36084726 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
ISO |
solasodine results in decreased expression of VIM mRNA; solasodine results in decreased expression of VIM protein CLDN2 protein inhibits the reaction [solasodine results in decreased expression of VIM protein] |
CTD |
PMID:37121296 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression |
ISO EXP |
[ABCB1A protein mutant form co-treated with ABCB1B protein mutant form] results in increased susceptibility to trabectedin trabectedin results in increased expression of ABCB1A mRNA |
CTD |
PMID:12154027 PMID:19238326 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
multiple interactions increases expression |
ISO EXP |
[ABCB1A protein mutant form co-treated with ABCB1B protein mutant form] results in increased susceptibility to trabectedin trabectedin results in increased expression of ABCB1B mRNA |
CTD |
PMID:12154027 PMID:19238326 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Aco1 |
aconitase 1 |
increases expression |
ISO |
Trabectedin results in increased expression of ACO1 mRNA; Trabectedin results in increased expression of ACO1 protein |
CTD |
PMID:36396105 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
trabectedin results in decreased expression of CAR3 mRNA |
CTD |
PMID:12154027 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
trabectedin results in decreased expression of CCNA2 mRNA |
CTD |
PMID:15961672 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
trabectedin results in decreased expression of CCNB1 mRNA |
CTD |
PMID:15961672 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
trabectedin results in decreased expression of CCNB2 mRNA |
CTD |
PMID:15961672 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
EXP |
trabectedin results in increased expression of CCND1 mRNA |
CTD |
PMID:12154027 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
increases expression |
ISO |
trabectedin results in increased expression of CCNE1 mRNA |
CTD |
PMID:15961672 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
EXP |
trabectedin results in increased expression of CDK1 mRNA |
CTD |
PMID:12154027 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases expression |
EXP |
trabectedin results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:12154027 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
EXP |
trabectedin results in decreased activity of CYP2E1 protein |
CTD |
PMID:12154027 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity |
EXP |
trabectedin results in decreased activity of CYP3A2 protein |
CTD |
PMID:12154027 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions |
EXP |
Trabectedin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA] |
CTD |
PMID:12504080 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
EXP |
trabectedin results in decreased expression of CYP3A13 mRNA |
CTD |
PMID:12154027 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
trabectedin results in decreased expression of DHFR mRNA |
CTD |
PMID:15961672 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression |
ISO |
trabectedin results in increased expression of E2F1 mRNA |
CTD |
PMID:15961672 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression |
ISO |
Trabectedin results in decreased expression of GPX4 mRNA; Trabectedin results in decreased expression of GPX4 protein |
CTD |
PMID:36396105 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression |
ISO |
Trabectedin results in increased expression of HIF1A mRNA; Trabectedin results in increased expression of HIF1A protein |
CTD |
PMID:36396105 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
increases expression |
ISO |
Trabectedin results in increased expression of KEAP1 protein |
CTD |
PMID:36396105 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
EXP |
trabectedin results in increased expression of MKI67 protein |
CTD |
PMID:12154027 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases response to substance |
ISO |
everolimus inhibits the reaction [MTOR results in decreased susceptibility to trabectedin] |
CTD |
PMID:21622721 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression |
ISO |
Trabectedin results in decreased expression of NFE2L2 protein |
CTD |
PMID:36396105 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfya |
nuclear transcription factor Y subunit alpha |
multiple interactions |
ISO |
trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein] |
CTD |
PMID:15961672 |
|
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
|
|
G |
Nfyb |
nuclear transcription factor Y subunit beta |
multiple interactions |
ISO |
trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein] |
CTD |
PMID:15961672 |
|
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
|
|
G |
Nfyc |
nuclear transcription factor Y subunit gamma |
multiple interactions |
ISO |
trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein] |
CTD |
PMID:15961672 |
|
NCBI chr 5:134,336,802...134,405,372
Ensembl chr 5:134,336,808...134,405,377
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
ISO |
Trabectedin results in increased expression of TFRC mRNA; Trabectedin results in increased expression of TFRC protein |
CTD |
PMID:36396105 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tk1 |
thymidine kinase 1 |
decreases expression |
ISO |
trabectedin results in decreased expression of TK1 mRNA |
CTD |
PMID:15961672 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
increases expression |
ISO |
triadimefon results in increased expression of AACS mRNA |
CTD |
PMID:17178688 |
|
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression increases expression |
EXP ISO |
triadimefon results in decreased expression of ABCB1 mRNA triadimefon results in increased expression of ABCB1 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO |
triadimefon results in decreased expression of ABCB4 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcb9 |
ATP binding cassette subfamily B member 9 |
increases expression |
EXP |
triadimefon results in increased expression of ABCB9 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr12:32,499,213...32,531,932
Ensembl chr12:32,499,225...32,531,931
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
triadimefon results in increased expression of ABCC3 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
ISO |
triadimefon results in increased expression of ABCC4 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
increases expression |
ISO |
triadimefon results in increased expression of ABCG1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
increases expression |
EXP |
triadimefon results in increased expression of ABCG5 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
decreases expression |
ISO |
triadimefon results in decreased expression of ABI3BP mRNA |
CTD |
PMID:26705709 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Acbd3 |
acyl-CoA binding domain containing 3 |
increases expression |
EXP |
triadimefon results in increased expression of ACBD3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr13:92,455,813...92,484,556
Ensembl chr13:92,455,655...92,483,380
|
|
G |
Acoxl |
acyl-CoA oxidase-like |
decreases expression |
EXP |
triadimefon results in decreased expression of ACOXL mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:115,061,069...115,367,032
Ensembl chr 3:115,061,060...115,364,686
|
|
G |
Acp3 |
acid phosphatase 3 |
increases expression |
ISO |
triadimefon results in increased expression of ACP3 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
increases expression |
EXP |
triadimefon results in increased expression of ACSL3 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
triadimefon results in decreased expression of ACTA2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
triadimefon results in decreased expression of ACTB mRNA |
CTD |
PMID:19363144 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
decreases expression |
ISO |
triadimefon results in decreased expression of ACTG2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Actn1 |
actinin, alpha 1 |
decreases expression |
ISO |
triadimefon analog results in decreased expression of ACTN1 mRNA; triadimefon results in decreased expression of ACTN1 mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
increases expression |
EXP |
triadimefon results in increased expression of ADAMTS1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
increases expression |
EXP |
triadimefon results in increased expression of ADARB1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
|
|
G |
Adgrd1 |
adhesion G protein-coupled receptor D1 |
decreases expression |
ISO |
triadimefon results in decreased expression of ADGRD1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr12:27,488,908...27,603,714
Ensembl chr12:27,488,908...27,603,696
|
|
G |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
increases expression |
ISO |
triadimefon results in increased expression of ADGRF5 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
decreases expression |
ISO |
triadimefon results in decreased expression of ADGRG6 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
|
|
G |
Adgrl2 |
adhesion G protein-coupled receptor L2 |
affects expression |
ISO |
triadimefon affects the expression of ADGRL2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 2:237,696,055...238,327,141
Ensembl chr 2:237,696,056...238,327,141
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
decreases expression |
EXP |
triadimefon results in decreased expression of ADGRV1 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
increases expression |
EXP |
triadimefon results in increased expression of ADH1 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
decreases expression |
ISO |
triadimefon results in decreased expression of ADH4 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of ADHFE1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
|
|
G |
Adora2b |
adenosine A2B receptor |
decreases expression |
EXP |
triadimefon results in decreased expression of ADORA2B mRNA |
CTD |
PMID:19423681 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
EXP |
triadimefon results in decreased expression of AGTR1 mRNA; triadimefon results in decreased expression of AGTR1 protein |
CTD |
PMID:34508824 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahctf1 |
AT hook containing transcription factor 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of AHCTF1 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr13:91,481,936...91,536,391
Ensembl chr13:91,481,936...91,536,391
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases activity |
ISO |
triadimefon results in decreased activity of AHR protein |
CTD |
PMID:30203046 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
affects expression |
EXP |
triadimefon affects the expression of AHRR mRNA |
CTD |
PMID:20659493 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
triadimefon results in increased expression of AKR7A3 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
EXP |
triadimefon results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:34508824 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases expression |
EXP |
triadimefon results in increased expression of ALAS1 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
triadimefon results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:17178689 PMID:19409404 PMID:19423681 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
decreases expression |
EXP |
triadimefon results in decreased expression of ALDH4A1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Alkbh6 |
alkB homolog 6 |
increases expression |
EXP |
triadimefon results in increased expression of ALKBH6 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:85,563,511...85,568,977
Ensembl chr 1:85,563,592...85,568,973
|
|
G |
Alpk2 |
alpha-kinase 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of ALPK2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258
|
|
G |
Ang2 |
angiogenin, ribonuclease A family, member 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of ANG2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr15:24,398,330...24,415,909
Ensembl chr15:24,398,419...24,398,922
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd10 |
ankyrin repeat domain 10 |
affects expression |
ISO |
triadimefon affects the expression of ANKRD10 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
decreases expression |
EXP |
triadimefon results in decreased expression of ANKRD34B mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:23,651,083...23,668,041
Ensembl chr 2:23,651,474...23,668,030
|
|
G |
Ano4 |
anoctamin 4 |
decreases expression |
ISO |
triadimefon results in decreased expression of ANO4 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 7:23,329,015...23,738,423
Ensembl chr 7:23,329,070...23,738,434
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
ISO |
triadimefon results in decreased expression of ANXA1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
decreases expression |
ISO |
triadimefon results in decreased expression of ANXA3 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Ap3b1 |
adaptor related protein complex 3 subunit beta 1 |
increases expression |
EXP |
triadimefon results in increased expression of AP3B1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:25,600,069...25,800,937
Ensembl chr 2:25,600,040...25,800,935
|
|
G |
Apcs |
amyloid P component, serum |
increases expression |
ISO |
triadimefon results in increased expression of APCS mRNA |
CTD |
PMID:19363144 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apoa4 |
apolipoprotein A4 |
decreases expression |
EXP |
triadimefon results in decreased expression of APOA4 mRNA |
CTD |
PMID:16643972 PMID:19423681 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
EXP |
triadimefon results in increased expression of APP mRNA |
CTD |
PMID:19423681 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of AQP1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases activity |
ISO |
triadimefon inhibits the reaction [Metribolone results in increased activity of AR protein] triadimefon results in decreased activity of AR protein |
CTD |
PMID:18324785 PMID:21251949 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg1 |
arginase 1 |
increases expression |
EXP |
triadimefon results in increased expression of ARG1 mRNA |
CTD |
PMID:22664269 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
increases expression |
EXP |
triadimefon results in increased expression of ARNT2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153
|
|
G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of ASB1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 9:92,120,332...92,140,790
Ensembl chr 9:92,120,306...92,136,376
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
affects expression |
ISO |
triadimefon affects the expression of ASF1B mRNA |
CTD |
PMID:21195148 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Aspn |
asporin |
decreases expression |
ISO |
triadimefon results in decreased expression of ASPN mRNA |
CTD |
PMID:26705709 |
|
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
|
|
G |
Atf5 |
activating transcription factor 5 |
decreases expression |
EXP |
triadimefon results in decreased expression of ATF5 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atg16l2 |
autophagy related 16-like 2 |
increases expression |
ISO |
triadimefon results in increased expression of ATG16L2 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
ISO |
triadimefon results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
B3galt2 |
Beta-1,3-galactosyltransferase 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of B3GALT2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr13:55,389,406...55,398,419
Ensembl chr13:55,389,406...55,398,419
|
|
G |
B3gnt7 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
affects expression |
ISO |
triadimefon affects the expression of B3GNT7 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 9:86,956,220...86,960,171
Ensembl chr 9:86,956,220...86,960,170
|
|
G |
Baiap2 |
BAR/IMD domain containing adaptor protein 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of BAIAP2 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
increases expression |
EXP |
triadimefon results in increased expression of BARD1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects expression |
EXP |
triadimefon affects the expression of BAX mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bckdha |
branched chain keto acid dehydrogenase E1 subunit alpha |
decreases expression |
EXP |
triadimefon results in decreased expression of BCKDHA mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression multiple interactions |
ISO |
triadimefon results in increased expression of BIRC5 mRNA NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of BIRC5 mRNA] |
CTD |
PMID:25949234 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bloc1s3 |
biogenesis of lysosomal organelles complex-1, subunit 3 |
affects expression |
ISO |
triadimefon affects the expression of BLOC1S3 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:79,155,873...79,158,247
Ensembl chr 1:79,155,693...79,158,505
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
decreases expression |
EXP |
triadimefon results in decreased expression of BNIP3L mRNA |
CTD |
PMID:30047161 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Bola1 |
bolA family member 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of BOLA1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:183,758,515...183,771,445
Ensembl chr 2:183,758,441...183,781,576
|
|
G |
Bpifb2 |
BPI fold containing family B, member 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of BPIFB2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:142,356,990...142,377,053
Ensembl chr 3:142,358,051...142,377,044
|
|
G |
Btbd10 |
BTB domain containing 10 |
increases expression |
EXP |
triadimefon results in increased expression of BTBD10 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:167,431,311...167,489,320
Ensembl chr 1:167,431,329...167,489,916
|
|
G |
Btd |
biotinidase |
increases expression |
EXP |
triadimefon results in increased expression of BTD mRNA |
CTD |
PMID:30047161 |
|
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
|
|
G |
Bud31 |
BUD31 homolog |
increases expression |
EXP |
triadimefon results in increased expression of BUD31 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr12:9,462,838...9,470,387
Ensembl chr12:9,462,441...9,470,509
|
|
G |
Cacng2 |
calcium voltage-gated channel auxiliary subunit gamma 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of CACNG2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:109,572,838...109,698,516
Ensembl chr 7:109,574,459...109,697,227
|
|
G |
Capn7 |
calpain 7 |
decreases expression |
ISO |
triadimefon results in decreased expression of CAPN7 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905
|
|
G |
Casp2 |
caspase 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of CASP2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
triadimefon results in increased expression of CASP3 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
decreases expression |
ISO |
triadimefon results in decreased expression of CASP9 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
triadimefon results in decreased expression of CAT mRNA; triadimefon results in decreased expression of CAT protein |
CTD |
PMID:34508824 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
decreases expression |
ISO |
triadimefon analog results in decreased expression of CAV1 mRNA; triadimefon results in decreased expression of CAV1 mRNA |
CTD |
PMID:26238599 PMID:26705709 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cav2 |
caveolin 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of CAV2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
|
|
G |
Cavin2 |
caveolae associated protein 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of CAVIN2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression |
EXP |
triadimefon results in increased expression of PRKCDBP mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cblc |
Cbl proto-oncogene C |
decreases expression |
ISO |
triadimefon results in decreased expression of CBLC mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 1:79,439,975...79,456,755
Ensembl chr 1:79,439,977...79,456,755
|
|
G |
Cbll1 |
Cbl proto-oncogene like 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of CBLL1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:48,071,190...48,086,174
Ensembl chr 6:48,071,190...48,086,444
|
|
G |
Cbx8 |
chromobox 8 |
affects expression |
ISO |
triadimefon affects the expression of CBX8 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:104,294,518...104,296,956
Ensembl chr10:104,294,518...104,297,024
|
|
G |
Ccdc112 |
coiled-coil domain containing 112 |
decreases expression |
EXP |
triadimefon results in decreased expression of CCDC112 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr18:38,998,139...39,032,329
Ensembl chr18:38,998,139...39,032,329
|
|
G |
Ccdc126 |
coiled-coil domain containing 126 |
decreases expression |
EXP |
triadimefon results in decreased expression of CCDC126 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 4:78,297,625...78,318,655
Ensembl chr 4:78,297,551...78,318,655
|
|
G |
Ccdc81 |
coiled-coil domain containing 81 |
decreases expression |
ISO |
triadimefon results in decreased expression of CCDC81 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:143,739,472...143,791,026
Ensembl chr 1:143,739,474...143,790,926
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
EXP |
triadimefon results in increased expression of CCL5 mRNA; triadimefon results in increased expression of CCL5 protein |
CTD |
PMID:36179991 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of CTGF mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccne2 |
cyclin E2 |
affects expression |
ISO |
triadimefon affects the expression of CCNE2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccng2 |
cyclin G2 |
affects expression |
ISO |
triadimefon affects the expression of CCNG2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cd9 |
CD9 molecule |
decreases expression |
ISO EXP |
triadimefon results in decreased expression of CD9 mRNA |
CTD |
PMID:26705709 PMID:30047161 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdc42 |
cell division cycle 42 |
affects expression |
ISO |
triadimefon affects the expression of CDC42 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
|
|
G |
Cdc42ep3 |
CDC42 effector protein 3 |
increases expression |
EXP |
triadimefon results in increased expression of CDC42EP3 mRNA |
CTD |
PMID:28263823 |
|
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
triadimefon results in increased expression of CDKN1A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdx1 |
caudal type homeo box 1 |
affects expression |
ISO |
triadimefon affects the expression of CDX1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
affects expression |
ISO |
triadimefon affects the expression of CEBPG mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Ces2h |
carboxylesterase 2H |
increases expression |
ISO EXP |
triadimefon results in increased expression of CES2 mRNA |
CTD |
PMID:16643972 PMID:16730040 PMID:19409404 PMID:19423681 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression |
EXP |
triadimefon results in decreased expression of CES3 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of CHEK2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
increases expression decreases expression |
ISO EXP |
triadimefon results in increased expression of CHI3L1 mRNA triadimefon results in decreased expression of CHI3L1 mRNA |
CTD |
PMID:26705709 PMID:30047161 |
|
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chsy1 |
chondroitin sulfate synthase 1 |
increases expression |
EXP |
triadimefon results in increased expression of CHSY1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:119,689,626...119,750,711
Ensembl chr 1:119,686,350...119,750,601
|
|
G |
Chtf18 |
chromosome transmission fidelity factor 18 |
increases expression |
EXP |
triadimefon results in increased expression of CHTF18 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
|
|
G |
Ciao2a |
cytosolic iron-sulfur assembly component 2A |
increases expression |
EXP |
triadimefon results in increased expression of FAM96A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:66,670,533...66,682,455
Ensembl chr 8:66,670,483...66,682,455
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP ISO |
triadimefon results in decreased expression of CLDN1 mRNA |
CTD |
PMID:19423681 PMID:26705709 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Clec14a |
C-type lectin domain containing 14A |
increases expression |
EXP |
triadimefon results in increased expression of CLEC14A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:75,881,470...75,884,612
Ensembl chr 6:75,881,473...75,884,612
|
|
G |
Clk1 |
CDC-like kinase 1 |
affects expression |
ISO |
triadimefon affects the expression of CLK1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
|
|
G |
Clrn2 |
clarin 2 |
increases expression |
EXP |
triadimefon results in increased expression of CLRN2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:65,656,029...65,666,325
Ensembl chr14:65,656,550...65,666,193
|
|
G |
Cnih4 |
cornichon family member 4 |
increases expression |
EXP |
triadimefon results in increased expression of CNIH4 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr13:92,910,315...92,926,428
Ensembl chr13:92,910,315...92,927,853
|
|
G |
Cnn1 |
calponin 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of CNN1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Col5a3 |
collagen type V alpha 3 chain |
increases expression |
EXP |
triadimefon results in increased expression of COL5A3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
increases expression |
EXP |
triadimefon results in increased expression of COMMD1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501
|
|
G |
Commd8 |
COMM domain containing 8 |
increases expression |
EXP |
triadimefon results in increased expression of COMMD8 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:36,049,040...36,059,617
Ensembl chr14:36,049,004...36,059,617
|
|
G |
Corin |
corin, serine peptidase |
decreases expression |
ISO |
triadimefon results in decreased expression of CORIN mRNA |
CTD |
PMID:26705709 |
|
NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
affects expression |
EXP |
triadimefon affects the expression of CPT1A mRNA |
CTD |
PMID:17383973 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
decreases expression |
EXP |
triadimefon results in decreased expression of CPT1C mRNA; triadimefon results in decreased expression of CPT1C protein |
CTD |
PMID:36179991 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
increases expression |
EXP |
triadimefon results in increased expression of CRABP1 protein |
CTD |
PMID:18976680 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
EXP |
triadimefon results in decreased expression of CREM mRNA |
CTD |
PMID:19423681 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Cripto |
cripto, EGF-CFC family member |
affects expression |
ISO |
triadimefon affects the expression of CRIPTO mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 8:110,924,774...110,938,545
Ensembl chr 8:110,925,024...110,930,308
|
|
G |
Crp |
C-reactive protein |
increases expression |
ISO |
triadimefon results in increased expression of CRP mRNA |
CTD |
PMID:19363144 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
increases expression |
EXP |
triadimefon results in increased expression of CRY1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cryab |
crystallin, alpha B |
decreases expression |
ISO |
triadimefon results in decreased expression of CRYAB mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csf1 |
colony stimulating factor 1 |
decreases expression |
ISO |
triadimefon analog results in decreased expression of CSF1 mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Ctdsp2 |
CTD small phosphatase 2 |
affects expression |
ISO |
triadimefon affects the expression of CTDSP2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 7:62,805,398...62,825,306
Ensembl chr 7:62,805,658...62,825,302
|
|
G |
Cttnbp2nl |
CTTNBP2 N-terminal like |
increases expression |
EXP |
triadimefon results in increased expression of CTTNBP2NL mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
increases expression |
EXP |
triadimefon results in increased expression of CX3CR1 mRNA; triadimefon results in increased expression of CX3CR1 protein |
CTD |
PMID:36179991 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of CXCL2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of CYP11B1 mRNA; triadimefon results in decreased expression of CYP11B1 protein |
CTD |
PMID:34508824 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
decreases expression |
EXP |
triadimefon results in decreased expression of CYP11B2 mRNA; triadimefon results in decreased expression of CYP11B2 protein |
CTD |
PMID:34508824 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity |
ISO |
triadimefon results in decreased activity of CYP19A1 protein |
CTD |
PMID:10806373 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
triadimefon results in increased expression of CYP1A1 mRNA; triadimefon results in increased expression of CYP1A1 protein |
CTD |
PMID:17178689 PMID:19409404 PMID:20659493 PMID:36179991 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
triadimefon results in increased expression of CYP1A2 mRNA |
CTD |
PMID:20659493 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
triadimefon results in increased expression of CYP1B1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
increases expression |
ISO |
triadimefon results in increased expression of CYP24A1 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
ISO EXP |
triadimefon results in increased expression of CYP26A1 mRNA |
CTD |
PMID:19010342 PMID:22664269 PMID:28263823 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
increases expression |
EXP |
triadimefon results in increased expression of CYP27B1 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
triadimefon results in increased expression of CYP2B1 mRNA; triadimefon results in increased expression of CYP2B1 protein |
CTD |
PMID:17178689 PMID:17484520 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
triadimefon results in increased expression of CYP2B2 mRNA; triadimefon results in increased expression of CYP2B2 protein |
CTD |
PMID:17178689 PMID:17484520 PMID:19409404 PMID:19423681 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
affects expression multiple interactions increases expression |
EXP ISO |
triadimefon affects the expression of CYP2B3 mRNA NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:17383973 PMID:19010342 PMID:23970803 PMID:25949234 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
increases expression |
ISO |
triadimefon results in increased expression of CYP2C55 mRNA |
CTD |
PMID:16730040 PMID:23970803 |
|
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases expression |
ISO |
triadimefon results in decreased expression of CYP2C29 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
increases expression |
ISO EXP |
triadimefon results in increased expression of CYP2J9 mRNA |
CTD |
PMID:16643972 PMID:16730040 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
increases expression |
EXP |
triadimefon results in increased expression of CYP2U1 mRNA |
CTD |
PMID:28263823 |
|
NCBI chr 2:219,849,403...219,866,959
Ensembl chr 2:219,849,407...219,866,882
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
increases expression |
EXP |
triadimefon results in increased expression of CYP3A18 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression multiple interactions |
EXP ISO |
triadimefon results in increased expression of CYP3A2 mRNA; triadimefon results in increased expression of CYP3A2 protein [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with penconazole] results in increased expression of CYP3A4 mRNA |
CTD |
PMID:17484520 PMID:25028461 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression affects expression |
EXP |
triadimefon results in increased expression of CYP3A23-3A1 mRNA; triadimefon results in increased expression of CYP3A23-3A1 protein triadimefon affects the expression of CYP3A23-3A1 mRNA |
CTD |
PMID:16643972 PMID:17383973 PMID:17484520 PMID:19409404 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression |
ISO |
triadimefon results in increased expression of CYP3A13 mRNA |
CTD |
PMID:19010342 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression decreases activity |
ISO EXP |
triadimefon results in increased expression of CYP51 mRNA triadimefon results in decreased activity of CYP51A1 protein |
CTD |
PMID:16989930 PMID:17178688 PMID:17178689 PMID:25949234 PMID:29337257 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
increases expression |
EXP |
triadimefon results in increased expression of DACT2 mRNA |
CTD |
PMID:28263823 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dad1 |
defender against cell death 1 |
increases expression |
EXP |
triadimefon results in increased expression of DAD1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of DAPK1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dars1 |
aspartyl-tRNA synthetase 1 |
affects expression |
ISO |
triadimefon affects the expression of DARS1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr13:39,857,936...39,913,055
Ensembl chr13:39,857,936...39,913,116
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
decreases expression |
EXP |
triadimefon results in decreased expression of DBP mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
affects expression |
ISO |
triadimefon affects the expression of DDIT4 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddx20 |
DEAD-box helicase 20 |
decreases expression |
EXP |
triadimefon results in decreased expression of DDX20 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:193,158,761...193,168,484
Ensembl chr 2:193,158,823...193,166,774
|
|
G |
Ddx46 |
DEAD-box helicase 46 |
decreases expression |
ISO |
triadimefon results in decreased expression of DDX46 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of DGAT2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
ISO |
triadimefon results in increased expression of DHCR7 mRNA |
CTD |
PMID:17178688 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
EXP |
triadimefon results in increased expression of DHRS3 mRNA |
CTD |
PMID:22664269 PMID:28263823 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrsx |
dehydrogenase/reductase X-linked |
decreases expression |
EXP |
triadimefon results in decreased expression of DHRSX mRNA |
CTD |
PMID:30047161 |
|
NCBI chr12:16,299,768...16,304,553
Ensembl chr12:16,299,808...16,304,552
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
affects expression |
EXP |
triadimefon affects the expression of DIO3 mRNA |
CTD |
PMID:17383973 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dipk1b |
divergent protein kinase domain 1B |
decreases expression |
EXP |
triadimefon results in decreased expression of FAM69B mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:9,455,914...9,464,169
Ensembl chr 3:9,456,409...9,464,161
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
increases expression |
EXP |
triadimefon results in increased expression of DLL1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dnajb13 |
DnaJ heat shock protein family (Hsp40) member B13 |
decreases expression |
EXP |
triadimefon results in decreased expression of DNAJB13 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:154,848,594...154,862,963
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
triadimefon results in increased expression of DNAJB4 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression |
ISO |
triadimefon results in increased expression of DNAJB9 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc19 |
DnaJ heat shock protein family (Hsp40) member C19 |
increases expression |
EXP |
triadimefon results in increased expression of DNAJC19 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:116,923,272...116,945,312
Ensembl chr 2:116,923,272...116,945,264
|
|
G |
Dok4 |
docking protein 4 |
increases expression |
EXP |
triadimefon results in increased expression of DOK4 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr19:10,146,520...10,157,187
Ensembl chr19:10,146,474...10,158,203
|
|
G |
Dpf2 |
double PHD fingers 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of DPF2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:203,183,674...203,199,037
Ensembl chr 1:203,183,686...203,198,983
|
|
G |
Dph1 |
diphthamide biosynthesis 1 |
increases expression |
EXP |
triadimefon results in increased expression of DPH1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:60,028,081...60,039,764
Ensembl chr10:60,026,048...60,039,850
|
|
G |
Dph3 |
diphthamide biosynthesis 3 |
increases expression |
EXP |
triadimefon results in increased expression of DPH3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
|
|
G |
Dpm3 |
dolichyl-phosphate mannosyltransferase subunit 3, regulatory |
increases expression |
EXP |
triadimefon results in increased expression of DPM3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:174,676,532...174,677,047
Ensembl chr 2:174,676,363...174,677,668 Ensembl chr15:174,676,363...174,677,668
|
|
G |
Dsp |
desmoplakin |
decreases expression |
ISO |
triadimefon results in decreased expression of DSP mRNA |
CTD |
PMID:26705709 |
|
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
|
|
G |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
decreases expression |
EXP |
triadimefon results in decreased expression of DSTYK mRNA |
CTD |
PMID:30047161 |
|
NCBI chr13:43,857,266...43,905,280
Ensembl chr13:43,857,266...43,905,269
|
|
G |
Dtx2 |
deltex E3 ubiquitin ligase 2 |
increases expression |
EXP |
triadimefon results in increased expression of DTX2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr12:20,643,289...20,682,908
Ensembl chr12:20,643,297...20,682,885
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
EXP |
triadimefon results in increased expression of DUSP5 mRNA |
CTD |
PMID:22664269 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
EXP |
triadimefon results in increased expression of DUSP6 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dvl1 |
dishevelled segment polarity protein 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of DVL1 mRNA |
CTD |
PMID:36179991 |
|
NCBI chr 5:166,456,989...166,468,733
Ensembl chr 5:166,456,686...166,468,664
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
increases expression |
EXP |
triadimefon results in increased expression of ECHDC1 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 1:28,476,354...28,507,173
Ensembl chr 1:28,476,200...28,507,319
|
|
G |
Ecscr |
endothelial cell surface expressed chemotaxis and apoptosis regulator |
decreases expression |
ISO |
triadimefon results in decreased expression of ECSCR mRNA |
CTD |
PMID:26705709 |
|
NCBI chr18:27,309,711...27,319,106
Ensembl chr18:27,309,718...27,319,032
|
|
G |
Edn1 |
endothelin 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of EDN1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of EEF1A1 mRNA |
CTD |
PMID:27015953 |
|
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
decreases expression |
EXP |
triadimefon results in decreased expression of EEF2K mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
ISO |
triadimefon results in decreased expression of EGF mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
increases expression |
EXP |
triadimefon results in increased expression of EGFLAM mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:56,301,945...56,476,665
Ensembl chr 2:56,302,566...56,476,298
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
triadimefon results in increased expression of EGR1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Egr2 |
early growth response 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of EGR2 mRNA |
CTD |
PMID:22664269 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Egr3 |
early growth response 3 |
increases expression |
ISO |
triadimefon results in increased expression of EGR3 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
affects expression |
ISO |
triadimefon affects the expression of EIF1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
increases expression |
ISO |
triadimefon results in increased expression of EIF4A2 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases expression |
ISO |
triadimefon results in increased expression of EIF4E mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of ELAPOR1 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
|
|
G |
Ell2 |
elongation factor for RNA polymerase II 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of ELL2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
|
|
G |
Elob |
elongin B |
increases expression |
EXP |
triadimefon results in increased expression of TCEB2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:12,848,830...12,853,897
Ensembl chr10:12,848,827...12,853,635
|
|
G |
Eme2 |
essential meiotic structure-specific endonuclease subunit 2 |
increases expression |
EXP |
triadimefon results in increased expression of EME2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:13,913,216...13,915,991
Ensembl chr10:13,913,221...13,915,968
|
|
G |
Eml5 |
EMAP like 5 |
decreases expression |
EXP |
triadimefon results in decreased expression of EML5 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831
|
|
G |
Enho |
energy homeostasis associated |
decreases expression |
ISO |
triadimefon results in decreased expression of ENHO mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 5:56,800,980...56,802,777
Ensembl chr 5:56,800,980...56,802,777
|
|
G |
Epha2 |
Eph receptor A2 |
decreases activity |
ISO |
triadimefon results in decreased activity of EPHA2 protein |
CTD |
PMID:21251949 |
|
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
|
|
G |
Epm2aip1 |
EPM2A interacting protein 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of EPM2AIP1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
|
|
G |
Eppin |
epididymal peptidase inhibitor |
decreases expression |
EXP |
triadimefon results in decreased expression of EPPIN mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:153,312,396...153,319,310
Ensembl chr 3:153,312,396...153,319,310
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
triadimefon results in increased expression of EREG mRNA |
CTD |
PMID:26705709 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Erg |
ETS transcription factor ERG |
decreases expression |
ISO |
triadimefon results in decreased expression of ERG mRNA |
CTD |
PMID:26705709 |
|
NCBI chr11:34,678,614...34,900,951
Ensembl chr11:34,678,618...34,845,871
|
|
G |
Esam |
endothelial cell adhesion molecule |
increases expression |
EXP |
triadimefon results in increased expression of ESAM mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases expression |
ISO |
triadimefon binds to and results in increased activity of ESR1 protein triadimefon results in increased expression of ESR1 mRNA |
CTD |
PMID:10789375 PMID:19363144 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Extl1 |
exostosin-like glycosyltransferase 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of EXTL1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:146,573,911...146,589,115
Ensembl chr 5:146,573,912...146,589,115
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
decreases expression |
EXP |
triadimefon results in decreased expression of F2RL3 mRNA |
CTD |
PMID:28263823 |
|
NCBI chr16:17,117,441...17,119,434
Ensembl chr16:17,117,441...17,119,472
|
|
G |
Fa2h |
fatty acid 2-hydroxylase |
decreases expression |
EXP |
triadimefon results in decreased expression of FA2H mRNA |
CTD |
PMID:30047161 |
|
NCBI chr19:39,312,904...39,364,153
Ensembl chr19:39,312,906...39,364,153
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
decreases expression |
ISO |
triadimefon results in decreased expression of FABP4 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
decreases expression |
EXP |
triadimefon results in decreased expression of FAH mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam13b |
family with sequence similarity 13, member B |
decreases expression |
EXP |
triadimefon results in decreased expression of FAM13B mRNA |
CTD |
PMID:30047161 |
|
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of FBN1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbxo27 |
F-box protein 27 |
decreases expression |
EXP |
triadimefon results in decreased expression of FBXO27 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:83,965,426...83,987,781
Ensembl chr 1:83,965,986...83,987,778
|
|
G |
Fbxo42 |
F-box protein 42 |
increases expression |
EXP |
triadimefon results in increased expression of FBXO42 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:153,451,162...153,509,564
Ensembl chr 5:153,451,153...153,506,342
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression affects expression |
ISO |
triadimefon results in increased expression of FDFT1 mRNA triadimefon affects the expression of FDFT1 mRNA |
CTD |
PMID:17178688 PMID:21195148 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
increases expression |
EXP |
triadimefon results in increased expression of FEN1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgl1 |
fibrinogen-like 1 |
increases expression |
ISO |
triadimefon results in increased expression of FGL1 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression |
ISO |
triadimefon results in increased expression of FKBP1A mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Flt4 |
Fms related receptor tyrosine kinase 4 |
decreases expression |
EXP |
triadimefon results in decreased expression of FLT4 mRNA |
CTD |
PMID:36179991 |
|
NCBI chr10:33,913,725...33,954,770
Ensembl chr10:33,913,608...33,954,770
|
|
G |
Fnbp1l |
formin binding protein 1-like |
decreases expression |
EXP |
triadimefon results in decreased expression of FNBP1L mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:210,647,241...210,748,203
Ensembl chr 2:210,647,246...210,738,455
|
|
G |
Foxb1 |
forkhead box B1 |
affects expression decreases expression |
ISO EXP |
triadimefon affects the expression of FOXB1 mRNA triadimefon results in decreased expression of FOXB1 mRNA |
CTD |
PMID:21195148 PMID:30047161 |
|
NCBI chr 8:70,407,221...70,409,841
Ensembl chr 8:70,408,186...70,409,781
|
|
G |
Foxc1 |
forkhead box C1 |
decreases expression |
EXP |
triadimefon results in decreased expression of FOXC1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
|
|
G |
Foxp1 |
forkhead box P1 |
decreases expression |
EXP |
triadimefon results in decreased expression of FOXP1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Fst |
follistatin |
increases expression |
ISO |
triadimefon results in increased expression of FST mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Gabarap |
GABA type A receptor-associated protein |
decreases expression |
EXP |
triadimefon results in decreased expression of GABARAP mRNA |
CTD |
PMID:16643972 |
|
NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765
|
|
G |
Gabbr1 |
gamma-aminobutyric acid type B receptor subunit 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of GABBR1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of GABRA2 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr14:37,097,251...37,230,030
Ensembl chr14:37,097,279...37,228,944
|
|
G |
Gabrg3 |
gamma-aminobutyric acid type A receptor subunit gamma 3 |
increases expression |
EXP |
triadimefon results in increased expression of GABRG3 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 1:107,627,450...108,247,483
Ensembl chr 1:107,627,390...108,246,763
|
|
G |
Gabrr1 |
gamma-aminobutyric acid type A receptor subunit rho 1 |
increases expression |
ISO |
triadimefon results in increased expression of GABRR1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 5:47,524,151...47,561,228
Ensembl chr 5:47,524,151...47,561,228
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
triadimefon results in increased expression of GADD45B mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
increases expression |
EXP |
triadimefon results in increased expression of GARS1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gas2 |
growth arrest-specific 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of GAS2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of GBE1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of GBP1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gbx2 |
gastrulation brain homeobox 2 |
affects expression increases expression |
ISO EXP |
triadimefon affects the expression of GBX2 mRNA triadimefon results in increased expression of GBX2 mRNA |
CTD |
PMID:21195148 PMID:28263823 |
|
NCBI chr 9:90,509,633...90,512,212
Ensembl chr 9:90,509,633...90,512,212
|
|
G |
Gemin2 |
gem (nuclear organelle) associated protein 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of GEMIN2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:76,706,424...76,721,154
Ensembl chr 6:76,707,523...76,721,153
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of GFRA1 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Gli4 |
GLI family zinc finger 4 |
decreases expression |
EXP |
triadimefon results in decreased expression of GLI4 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:107,325,584...107,330,911
Ensembl chr 7:107,325,607...107,330,907
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of GLIPR1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Gmfg |
glia maturation factor, gamma |
increases expression |
EXP |
triadimefon results in increased expression of GMFG mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
|
|
G |
Gna14 |
G protein subunit alpha 14 |
decreases expression |
ISO |
triadimefon results in decreased expression of GNA14 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
|
|
G |
Gpr62 |
G protein-coupled receptor 62 |
decreases expression |
EXP |
triadimefon results in decreased expression of GPR62 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:107,103,225...107,105,311
Ensembl chr 8:107,103,980...107,105,056
|
|
G |
Gpr68 |
G protein-coupled receptor 68 |
decreases expression |
EXP |
triadimefon results in decreased expression of GPR68 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:120,135,620...120,166,089
Ensembl chr 6:120,135,436...120,166,089
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of GPX1 mRNA; triadimefon results in decreased expression of GPX1 protein |
CTD |
PMID:34508824 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gramd1b |
GRAM domain containing 1B |
increases expression |
EXP |
triadimefon results in increased expression of GRAMD1B mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:40,654,492...40,893,869
Ensembl chr 8:40,659,182...40,893,925
|
|
G |
Gramd1c |
GRAM domain containing 1C |
decreases expression |
EXP |
triadimefon results in decreased expression of GRAMD1C mRNA |
CTD |
PMID:30047161 |
|
NCBI chr11:56,633,229...56,718,570
Ensembl chr11:56,633,227...56,718,570
|
|
G |
Gramd2a |
GRAM domain containing 2A |
decreases expression |
EXP |
triadimefon results in decreased expression of GRAMD2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:60,079,744...60,117,788
Ensembl chr 8:60,080,338...60,115,842
|
|
G |
Gsc |
goosecoid homeobox |
decreases expression |
EXP |
triadimefon results in decreased expression of GSC mRNA |
CTD |
PMID:21254369 |
|
NCBI chr 6:123,388,072...123,390,111
Ensembl chr 6:123,388,072...123,390,111
|
|
G |
Gsr |
glutathione-disulfide reductase |
affects expression |
EXP |
triadimefon affects the expression of GSR mRNA |
CTD |
PMID:17383973 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
affects expression |
EXP |
triadimefon affects the expression of GSTA1 mRNA |
CTD |
PMID:17383973 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP ISO |
triadimefon results in increased expression of GSTA2 mRNA |
CTD |
PMID:16730040 PMID:17178689 PMID:25949234 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
triadimefon results in increased expression of GSTA5 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects expression |
EXP |
triadimefon affects the expression of GSTM1 mRNA |
CTD |
PMID:17383973 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
increases expression |
EXP |
triadimefon results in increased expression of GSTM4 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
multiple interactions increases expression |
ISO EXP |
NR1H3 gene mutant form promotes the reaction [triadimefon results in increased expression of GSTM3 mRNA] |
CTD |
PMID:16643972 PMID:23970803 PMID:25949234 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
ISO |
triadimefon results in increased expression of GSTT1 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Guca1a |
guanylate cyclase activator 1A |
decreases expression |
ISO |
triadimefon results in decreased expression of GUCA1A mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 9:13,588,988...13,598,566
Ensembl chr 9:13,588,525...13,598,565
|
|
G |
H1f0 |
H1.0 linker histone |
decreases expression |
ISO |
triadimefon results in decreased expression of H1F0 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
triadimefon results in increased expression of H2AX mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of HAO2 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of HAPLN1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777
|
|
G |
Hat1 |
histone acetyltransferase 1 |
increases expression |
EXP |
triadimefon results in increased expression of HAT1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of HCN1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
|
|
G |
Hdgfl3 |
HDGF like 3 |
increases expression |
EXP |
triadimefon results in increased expression of HDGFRP3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
affects expression |
ISO |
triadimefon affects the expression of HES1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hfe |
homeostatic iron regulator |
increases expression |
ISO |
triadimefon results in increased expression of HFE mRNA |
CTD |
PMID:16730040 |
|
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
|
|
G |
Hgfac |
HGF activator |
decreases expression |
ISO |
triadimefon results in decreased expression of HGFAC mRNA |
CTD |
PMID:19363144 |
|
NCBI chr14:75,707,588...75,714,182
Ensembl chr14:75,707,591...75,714,278
|
|
G |
Hist1h2bd |
histone cluster 1 H2B family member D |
increases expression |
EXP |
triadimefon results in increased expression of HIST1H2BD mRNA |
CTD |
PMID:30047161 |
|
NCBI chr17:42,792,887...42,793,268
|
|
G |
Hist1h4m |
histone cluster 1, H4m |
increases expression |
EXP |
triadimefon results in increased expression of HIST1H4M mRNA |
CTD |
PMID:30047161 |
|
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO EXP |
triadimefon results in increased expression of HMGCR mRNA |
CTD |
PMID:17178689 PMID:19363144 PMID:19423681 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
ISO EXP |
triadimefon results in increased expression of HMGCS1 mRNA |
CTD |
PMID:17178688 PMID:17178689 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hoxa1 |
homeobox A1 |
affects expression |
ISO |
triadimefon affects the expression of HOXA1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
|
|
G |
Hps6 |
HPS6, biogenesis of lysosomal organelles complex 2 subunit 3 |
affects expression |
ISO |
triadimefon affects the expression of HPS6 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:244,853,256...244,855,865
Ensembl chr 1:244,853,194...244,855,883
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases reduction |
EXP |
HSD11B1 protein results in increased reduction of triadimefon |
CTD |
PMID:18763812 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
increases expression |
EXP |
triadimefon results in increased expression of HSP90B1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa13 |
heat shock protein family A (Hsp70) member 13 |
increases expression |
ISO |
triadimefon results in increased expression of HSPA13 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
|
|
G |
Hspa4l |
heat shock protein family A (Hsp70) member 4 like |
decreases expression |
EXP |
triadimefon results in decreased expression of HSPA4L mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
EXP |
triadimefon results in decreased expression of HSPA5 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
ISO |
triadimefon results in increased expression of HSPA8 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
triadimefon results in increased expression of HTATIP2 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
affects expression |
ISO |
triadimefon affects the expression of ID2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
increases expression |
ISO EXP |
triadimefon results in increased expression of IDI1 mRNA |
CTD |
PMID:17178688 PMID:17178689 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier3 |
immediate early response 3 |
affects expression |
ISO |
triadimefon affects the expression of IER3 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Iffo1 |
intermediate filament family orphan 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of IFFO1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:157,945,075...157,962,302
Ensembl chr 4:157,945,107...157,962,302
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
increases expression |
EXP |
triadimefon results in increased expression of IFITM2 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ift43 |
intraflagellar transport 43 |
increases expression |
EXP |
triadimefon results in increased expression of IFT43 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of IGF1 mRNA; triadimefon results in decreased expression of IGF1 protein |
CTD |
PMID:34508824 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
increases expression |
ISO |
triadimefon results in increased expression of IKBKE mRNA |
CTD |
PMID:23970803 |
|
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
|
|
G |
Il17rd |
interleukin 17 receptor D |
affects expression |
ISO |
triadimefon affects the expression of IL17RD mRNA |
CTD |
PMID:21195148 |
|
NCBI chr16:2,228,438...2,295,122
Ensembl chr16:2,228,287...2,292,556
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
increases expression |
EXP |
triadimefon results in increased expression of IL1R1 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il5 |
interleukin 5 |
decreases expression |
EXP |
triadimefon results in decreased expression of IL5 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il7r |
interleukin 7 receptor |
decreases expression |
ISO |
triadimefon results in decreased expression of IL7R mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
affects expression |
ISO |
triadimefon affects the expression of IMPDH2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
ISO |
triadimefon results in decreased expression of INMT mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Inpp4a |
inositol polyphosphate-4-phosphatase type I A |
increases expression |
EXP |
triadimefon results in increased expression of INPP4A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 9:39,528,245...39,650,574
Ensembl chr 9:39,528,674...39,646,581
|
|
G |
Insig1 |
insulin induced gene 1 |
affects expression |
ISO |
triadimefon affects the expression of INSIG1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Insm2 |
INSM transcriptional repressor 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of INSM2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:72,973,861...72,976,453
|
|
G |
Ipo11-ps1 |
importin 11, pseudogene 1 |
increases expression |
EXP |
triadimefon results in increased expression of IPO11 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:123,087,818...123,090,978
Ensembl chr 6:123,087,873...123,091,059
|
|
G |
Irf6 |
interferon regulatory factor 6 |
increases expression |
EXP |
triadimefon results in increased expression of IRF6 mRNA |
CTD |
PMID:22664269 |
|
NCBI chr13:104,672,179...104,691,386
Ensembl chr13:104,672,179...104,691,386
|
|
G |
Irgm |
immunity-related GTPase M |
affects expression |
ISO |
triadimefon affects the expression of IRGM1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Itga4 |
integrin subunit alpha 4 |
decreases expression |
ISO |
triadimefon analog results in decreased expression of ITGA4 mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itgb3 |
integrin subunit beta 3 |
decreases expression |
ISO |
triadimefon analog results in decreased expression of ITGB3 mRNA |
CTD |
PMID:26238599 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Itgbl1 |
integrin subunit beta like 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of ITGBL1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr15:100,780,184...101,041,734
Ensembl chr15:100,780,184...101,041,733
|
|
G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
decreases expression |
ISO |
triadimefon results in decreased expression of ITIH3 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
|
|
G |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
affects expression |
ISO |
triadimefon affects the expression of JAKMIP1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr14:73,646,299...73,766,830
Ensembl chr14:73,632,428...73,713,993
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
affects expression |
ISO |
triadimefon affects the expression of JMJD6 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
|
|
G |
Jmjd7 |
jumonji domain containing 7 |
increases expression |
EXP |
triadimefon results in increased expression of JMJD7 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:106,998,454...107,004,538
Ensembl chr 3:106,998,477...107,004,538
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
triadimefon results in increased expression of JUND mRNA |
CTD |
PMID:16643972 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kalrn |
kalirin, RhoGEF kinase |
decreases expression |
ISO |
triadimefon results in decreased expression of KALRN mRNA |
CTD |
PMID:26705709 |
|
NCBI chr11:66,198,155...66,803,166
Ensembl chr11:66,198,173...66,797,610
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
decreases expression |
ISO |
triadimefon results in decreased expression of KAT2B mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Kcnh1 |
potassium voltage-gated channel subfamily H member 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of KCNH1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
|
|
G |
Kdm8 |
lysine demethylase 8 |
increases expression |
EXP |
triadimefon results in increased expression of KDM8 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:180,013,969...180,028,829
Ensembl chr 1:180,020,656...180,028,841
|
|
G |
Klf2 |
KLF transcription factor 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of KLF2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klrg1 |
killer cell lectin like receptor G1 |
increases expression |
EXP |
triadimefon results in increased expression of KLRG1 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 4:155,455,465...155,467,301
Ensembl chr 4:155,455,495...155,467,424
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
increases expression |
ISO |
triadimefon results in increased expression of KPNA2 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
increases expression |
ISO |
triadimefon results in increased expression of KPNB1 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Krt14 |
keratin 14 |
decreases expression |
EXP |
triadimefon results in decreased expression of KRT14 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt18 |
keratin 18 |
decreases expression |
ISO |
triadimefon results in decreased expression of KRT18 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt19 |
keratin 19 |
decreases expression |
ISO |
triadimefon results in decreased expression of KRT19 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Ldlr |
low density lipoprotein receptor |
affects expression decreases expression |
ISO EXP |
triadimefon affects the expression of LDLR mRNA triadimefon results in decreased expression of LDLR mRNA |
CTD |
PMID:21195148 PMID:36179991 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lifr |
LIF receptor subunit alpha |
decreases expression |
EXP |
triadimefon results in decreased expression of LIFR mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of LMCD1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Lmo4 |
LIM domain only 4 |
increases expression |
ISO |
triadimefon results in increased expression of LMO4 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:233,264,180...233,280,881
Ensembl chr 2:233,264,182...233,280,880
|
|
G |
Lpl |
lipoprotein lipase |
increases expression |
ISO |
triadimefon results in increased expression of LPL mRNA |
CTD |
PMID:26705709 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lrp8 |
LDL receptor related protein 8 |
affects expression |
ISO |
triadimefon affects the expression of LRP8 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
|
|
G |
Lrrc32 |
leucine rich repeat containing 32 |
decreases expression |
ISO |
triadimefon results in decreased expression of LRRC32 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:152,785,709...152,802,997
Ensembl chr 1:152,786,511...152,798,373
|
|
G |
Lrrc45 |
leucine rich repeat containing 45 |
decreases expression |
EXP |
triadimefon results in decreased expression of LRRC45 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:105,994,468...106,002,425
Ensembl chr10:105,993,087...106,002,424
|
|
G |
Lrrc75a |
leucine rich repeat containing 75A |
increases expression |
EXP |
triadimefon results in increased expression of LRRC75A mRNA |
CTD |
PMID:22664269 PMID:28263823 |
|
NCBI chr10:47,298,222...47,343,301
Ensembl chr10:47,297,288...47,343,664
|
|
G |
Lsm11 |
LSM11, U7 small nuclear RNA associated |
affects expression |
ISO |
triadimefon affects the expression of LSM11 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:30,367,841...30,385,956
Ensembl chr10:30,370,727...30,385,944
|
|
G |
Lsm3 |
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
EXP |
triadimefon results in increased expression of LSM3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:124,021,023...124,027,269
Ensembl chr 4:124,021,023...124,027,269
|
|
G |
Lss |
lanosterol synthase |
affects expression |
ISO |
triadimefon affects the expression of LSS mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Luc7l |
LUC7-like |
affects expression |
ISO |
triadimefon affects the expression of LUC7L mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:15,273,340...15,307,131
Ensembl chr10:15,273,348...15,303,112
|
|
G |
Lxn |
latexin |
increases expression |
EXP |
triadimefon results in increased expression of LXN mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
|
|
G |
Mad1l1 |
mitotic arrest deficient 1 like 1 |
increases expression |
EXP |
triadimefon results in increased expression of MAD1L1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr12:14,320,892...14,630,750
Ensembl chr12:14,320,892...14,630,703
|
|
G |
Maf1 |
MAF1 homolog, negative regulator of RNA polymerase III |
decreases expression |
EXP |
triadimefon results in decreased expression of MAF1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:108,075,173...108,078,252
Ensembl chr 7:108,075,189...108,078,249
|
|
G |
Mafb |
MAF bZIP transcription factor B |
decreases expression |
EXP |
triadimefon results in decreased expression of MAFB mRNA |
CTD |
PMID:22664269 |
|
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
|
|
G |
Magoh |
mago homolog, exon junction complex subunit |
increases expression |
EXP |
triadimefon results in increased expression of MAGOH mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:122,639,268...122,646,650
Ensembl chr 5:122,639,308...122,646,617
|
|
G |
Mamdc2 |
MAM domain containing 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of MAMDC2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
EXP |
triadimefon results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:34508824 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
EXP |
triadimefon results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:34508824 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
increases expression |
EXP |
triadimefon results in increased expression of MARCKS mRNA |
CTD |
PMID:30047161 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mc2r |
melanocortin 2 receptor |
decreases expression |
EXP |
triadimefon results in decreased expression of MC2R mRNA; triadimefon results in decreased expression of MC2R protein |
CTD |
PMID:34508824 |
|
NCBI chr18:62,001,980...62,015,567
Ensembl chr18:62,004,948...62,015,488
|
|
G |
Mcam |
melanoma cell adhesion molecule |
decreases expression |
ISO |
triadimefon results in decreased expression of MCAM mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
|
|
G |
Med31 |
mediator complex subunit 31 |
decreases expression |
EXP |
triadimefon results in decreased expression of MED31 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326
|
|
G |
Meig1 |
meiosis/spermiogenesis associated 1 |
increases expression |
ISO |
triadimefon results in increased expression of MEIG1 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr17:74,810,791...74,828,433
Ensembl chr17:74,814,632...74,828,433
|
|
G |
Mesp2 |
mesoderm posterior bHLH transcription factor 2 |
affects expression |
ISO |
triadimefon affects the expression of MESP2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198
|
|
G |
Mettl16 |
methyltransferase 16, RNA N6-adenosine |
affects expression |
ISO |
triadimefon affects the expression of METTL16 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:59,640,915...59,697,291
Ensembl chr10:59,640,972...59,687,061
|
|
G |
Mfap5 |
microfibril associated protein 5 |
decreases expression |
ISO |
triadimefon results in decreased expression of MFAP5 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:155,727,925...155,750,458
Ensembl chr 4:155,727,925...155,750,458
|
|
G |
Mgll |
monoglyceride lipase |
decreases expression |
ISO |
triadimefon results in decreased expression of MGLL mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of MICAL2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:166,345,853...166,530,575
Ensembl chr 1:166,345,859...166,471,719 Ensembl chr 1:166,345,859...166,471,719
|
|
G |
Micb |
MHC class I polypeptide-related sequence B |
decreases expression |
ISO |
triadimefon results in decreased expression of MICB mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:78,495,779...78,513,030
Ensembl chr 1:78,495,779...78,512,827
|
|
G |
Mipol1 |
mirror-image polydactyly 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of MIPOL1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:74,755,293...75,090,403
Ensembl chr 6:74,755,395...75,086,811
|
|
G |
Mir135b |
microRNA 135b |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR135B mRNA |
CTD |
PMID:20175128 |
|
NCBI chr13:43,638,857...43,638,953
Ensembl chr13:43,638,857...43,638,953
|
|
G |
Mir205 |
microRNA 205 |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR205 mRNA |
CTD |
PMID:20175128 |
|
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
|
|
G |
Mir20b |
microRNA 20b |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR20B mRNA |
CTD |
PMID:23159985 |
|
NCBI chr X:132,422,211...132,422,282
Ensembl chr X:132,422,211...132,422,282
|
|
G |
Mir211 |
microRNA 211 |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR211 mRNA |
CTD |
PMID:20175128 |
|
NCBI chr 1:117,777,539...117,777,644
Ensembl chr 1:117,777,539...117,777,644
|
|
G |
Mir363 |
microRNA 363 |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR363 mRNA |
CTD |
PMID:20175128 PMID:23159985 |
|
NCBI chr X:132,421,791...132,421,877
Ensembl chr X:132,421,791...132,421,877
|
|
G |
Mir509 |
microRNA 509 |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR509 mRNA |
CTD |
PMID:20175128 |
|
NCBI chr X:146,688,132...146,688,216
Ensembl chr X:146,688,132...146,688,216
|
|
G |
Mir761 |
microRNA 761 |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR761 mRNA |
CTD |
PMID:20175128 |
|
NCBI chr 5:123,776,534...123,776,609
Ensembl chr 5:123,776,534...123,776,609
|
|
G |
Mir875 |
microRNA 875 |
decreases expression |
ISO |
triadimefon results in decreased expression of MIR875 mRNA |
CTD |
PMID:20175128 |
|
NCBI chr 7:66,861,955...66,862,027
Ensembl chr 7:66,861,955...66,862,027
|
|
G |
Mmp19 |
matrix metallopeptidase 19 |
decreases expression |
ISO |
triadimefon results in decreased expression of MMP19 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 7:1,221,229...1,229,555
Ensembl chr 7:1,221,343...1,229,555
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
triadimefon analog results in decreased expression of MMP9 mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mnx1 |
motor neuron and pancreas homeobox 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of MNX1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:5,866,506...5,871,465
Ensembl chr 4:5,866,506...5,871,465
|
|
G |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
affects expression |
ISO |
triadimefon affects the expression of MRM1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr10:69,690,406...69,697,326
Ensembl chr10:69,690,421...69,696,709
|
|
G |
Mrpl23 |
mitochondrial ribosomal protein L23 |
increases expression |
EXP |
triadimefon results in increased expression of MRPL23 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:197,687,452...197,695,222
Ensembl chr 1:197,687,347...197,695,222
|
|
G |
Mrpl27 |
mitochondrial ribosomal protein L27 |
increases expression |
EXP |
triadimefon results in increased expression of MRPL27 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:79,595,459...79,601,242
Ensembl chr10:79,595,479...79,601,239
|
|
G |
Mrps18b |
mitochondrial ribosomal protein S18B |
decreases expression |
ISO |
triadimefon results in decreased expression of MRPS18B mRNA |
CTD |
PMID:19363144 |
|
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
|
|
G |
Msi2 |
musashi RNA-binding protein 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of MSI2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:73,143,760...73,510,566
Ensembl chr10:73,147,380...73,510,157
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
affects expression |
ISO |
triadimefon affects the expression of MSMO1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Msx2 |
msh homeobox 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of MSX2 mRNA |
CTD |
PMID:21254369 |
|
NCBI chr17:11,097,214...11,102,879
Ensembl chr17:11,097,103...11,102,879
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
triadimefon results in increased expression of MT1 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
triadimefon results in increased expression of MT2 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
decreases expression |
EXP |
triadimefon results in decreased expression of MTHFR mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
increases expression |
ISO EXP |
triadimefon results in increased expression of MVD mRNA |
CTD |
PMID:17178688 PMID:17178689 |
|
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
|
|
G |
Mvk |
mevalonate kinase |
increases expression |
EXP |
triadimefon results in increased expression of MVK mRNA |
CTD |
PMID:19423681 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Myct1 |
myc target 1 |
increases expression |
EXP |
triadimefon results in increased expression of MYCT1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:42,018,137...42,029,410
Ensembl chr 1:42,018,137...42,029,410
|
|
G |
Myl12b |
myosin light chain 12B |
increases expression |
EXP |
triadimefon results in increased expression of MYL12B mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 9:110,873,855...110,888,187
|
|
G |
Myl9 |
myosin light chain 9 |
decreases expression |
ISO |
triadimefon results in decreased expression of MYL9 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Myo1d |
myosin ID |
increases expression |
EXP |
triadimefon results in increased expression of MYO1D mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
|
|
G |
Nags |
N-acetylglutamate synthase |
decreases expression |
EXP |
triadimefon results in decreased expression of NAGS mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:87,098,330...87,102,465
Ensembl chr10:87,098,330...87,102,465
|
|
G |
Nap1l3 |
nucleosome assembly protein 1-like 3 |
decreases expression |
EXP |
triadimefon results in decreased expression of NAP1L3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr X:88,347,595...88,350,393
Ensembl chr X:88,347,598...88,350,393
|
|
G |
Narf |
nuclear prelamin A recognition factor |
decreases expression |
EXP |
triadimefon results in decreased expression of NARF mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:106,519,508...106,537,494
Ensembl chr10:106,519,444...106,537,486
|
|
G |
Nasp |
nuclear autoantigenic sperm protein |
increases expression |
ISO |
triadimefon results in increased expression of NASP mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
increases expression |
ISO |
triadimefon results in increased expression of NDRG1 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndufab1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
decreases expression |
EXP |
triadimefon results in decreased expression of NDUFAB1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
|
|
G |
Nebl |
nebulette |
increases expression |
ISO |
triadimefon results in increased expression of NEBL mRNA |
CTD |
PMID:23970803 |
|
NCBI chr17:80,113,891...80,466,331
Ensembl chr17:80,118,543...80,466,210
|
|
G |
Nectin2 |
nectin cell adhesion molecule 2 |
affects expression |
ISO |
triadimefon affects the expression of NECTIN2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
|
|
G |
Neurod2 |
neuronal differentiation 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of NEUROD2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:83,323,801...83,327,986
Ensembl chr10:83,324,442...83,327,986
|
|
G |
Nexn |
nexilin (F actin binding protein) |
decreases expression |
ISO |
triadimefon results in decreased expression of NEXN mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity |
ISO |
triadimefon results in increased activity of NFE2L2 protein |
CTD |
PMID:30114225 PMID:30203046 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfia |
nuclear factor I/A |
decreases expression |
ISO |
triadimefon results in decreased expression of NFIA mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
affects expression |
ISO |
triadimefon affects the expression of NFIL3 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nkd2 |
NKD inhibitor of WNT signaling pathway 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of NKD2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:29,442,898...29,470,839
Ensembl chr 1:29,441,328...29,470,821
|
|
G |
Nnmt |
nicotinamide N-methyltransferase |
increases expression |
ISO |
triadimefon results in increased expression of NNMT mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
|
|
G |
Nnt |
nicotinamide nucleotide transhydrogenase |
increases expression |
EXP |
triadimefon results in increased expression of NNT mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
|
|
G |
Nop58 |
NOP58 ribonucleoprotein |
increases expression |
EXP |
triadimefon results in increased expression of NOP58 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
decreases expression |
ISO |
triadimefon results in decreased expression of NPR3 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
affects expression |
EXP |
triadimefon affects the expression of NQO1 mRNA |
CTD |
PMID:17383973 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of NR1D2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
multiple interactions |
ISO |
NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of BIRC5 mRNA]; NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of CYP2B10 mRNA]; NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of CYP3A11 mRNA]; NR1H3 gene mutant form promotes the reaction [triadimefon results in increased expression of GSTM3 mRNA] |
CTD |
PMID:25949234 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
[N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with penconazole] results in increased activity of NR1I2 protein; triadimefon binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 PMID:25028461 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
decreases expression increases activity |
ISO |
triadimefon results in decreased expression of NR1I3 mRNA triadimefon results in increased activity of NR1I3 protein |
CTD |
PMID:25949234 PMID:30203046 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of NR5A1 mRNA; triadimefon results in decreased expression of NR5A1 protein |
CTD |
PMID:34508824 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Nrbp2 |
nuclear receptor binding protein 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of NRBP2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:107,798,642...107,805,225
Ensembl chr 7:107,799,497...107,805,230
|
|
G |
Nrm |
nurim |
increases expression |
EXP |
triadimefon results in increased expression of NRM mRNA |
CTD |
PMID:30047161 |
|
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802
|
|
G |
Nsun7 |
NOP2/Sun RNA methyltransferase family member 7 |
decreases expression |
EXP |
triadimefon results in decreased expression of NSUN7 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:41,878,562...41,935,238
Ensembl chr14:41,879,293...41,934,949
|
|
G |
Nup155 |
nucleoporin 155 |
increases expression |
EXP |
triadimefon results in increased expression of NUP155 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:57,201,310...57,252,918
Ensembl chr 2:57,201,272...57,254,148
|
|
G |
Nup35 |
nucleoporin 35 |
increases expression |
EXP |
triadimefon results in increased expression of NUP35 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:65,555,203...65,594,488
Ensembl chr 3:65,558,968...65,585,130
|
|
G |
Nxt1 |
nuclear transport factor 2-like export factor 1 |
increases expression |
EXP |
triadimefon results in increased expression of NXT1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:136,108,975...136,111,897
Ensembl chr 3:136,108,862...136,111,907
|
|
G |
Obp2a |
odorant binding protein 2A |
decreases expression |
ISO |
triadimefon results in decreased expression of OBP2A mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 3:8,505,963...8,509,269
Ensembl chr 3:8,505,990...8,509,269
|
|
G |
Ogfr |
opioid growth factor receptor |
decreases expression |
EXP |
triadimefon results in decreased expression of OGFR mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:167,703,173...167,709,459
Ensembl chr 3:167,702,695...167,709,473
|
|
G |
Omd |
osteomodulin |
decreases expression |
ISO |
triadimefon results in decreased expression of OMD mRNA |
CTD |
PMID:26705709 |
|
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,060,217...15,068,441
|
|
G |
Onecut1 |
one cut homeobox 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of ONECUT1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:75,599,432...75,633,598
Ensembl chr 8:75,599,740...75,627,277
|
|
G |
Or13c7c |
olfactory receptor family 13 subfamily C member 7C |
decreases expression |
ISO |
triadimefon results in decreased expression of OR13C7 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 5:58,067,078...58,068,034
Ensembl chr 5:58,062,305...58,072,428
|
|
G |
Otogl |
otogelin-like |
decreases expression |
ISO |
triadimefon results in decreased expression of OTOGL mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 7:43,065,800...43,211,400
Ensembl chr 7:43,067,644...43,223,592
|
|
G |
Otx1 |
orthodenticle homeobox 1 |
affects expression |
ISO |
triadimefon affects the expression of OTX1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr14:96,082,146...96,089,161
Ensembl chr14:96,082,151...96,089,086
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
increases expression |
EXP |
triadimefon results in increased expression of P4HB mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of PABPC1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:67,777,438...67,789,731
Ensembl chr 7:67,777,381...67,789,744
|
|
G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
increases expression |
EXP |
triadimefon results in increased expression of PACSIN2 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:114,505,152...114,598,546
|
|
G |
Pam16 |
presequence translocase associated motor 16 |
increases expression |
EXP |
triadimefon results in increased expression of PAM16 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:10,942,534...10,950,654
Ensembl chr10:10,943,001...10,950,649
|
|
G |
Pappa |
pappalysin |
decreases expression |
ISO |
triadimefon results in decreased expression of PAPPA mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
increases expression |
ISO |
triadimefon results in increased expression of PAPSS2 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
decreases expression |
ISO |
triadimefon results in decreased expression of PAWR mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pc |
pyruvate carboxylase |
decreases expression |
EXP |
triadimefon results in decreased expression of PC mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pcdhgc3 |
protocadherin gamma subfamily C, 3 |
increases expression |
ISO |
triadimefon results in increased expression of PCDHGC3 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr18:29,633,016...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pde11a |
phosphodiesterase 11A |
decreases expression |
EXP |
triadimefon results in decreased expression of PDE11A mRNA |
CTD |
PMID:22664269 |
|
NCBI chr 3:60,913,562...61,297,154
Ensembl chr 3:60,913,562...61,297,158
|
|
G |
Pde4a |
phosphodiesterase 4A |
decreases expression |
EXP |
triadimefon results in decreased expression of PDE4A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961
|
|
G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
increases expression |
EXP |
triadimefon results in increased expression of PDIA4 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
|
|
G |
Pdxp |
pyridoxal phosphatase |
affects expression |
ISO |
triadimefon affects the expression of PDXP mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 7:110,472,515...110,477,963
Ensembl chr 7:110,472,515...110,477,963
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
increases expression |
EXP |
triadimefon results in increased expression of PGK1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of PIK3IP1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
affects expression |
ISO |
triadimefon affects the expression of PIM1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
|
|
G |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase type 1 beta |
increases expression |
ISO |
triadimefon results in increased expression of PIP5K1B mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:221,907,220...222,183,672
Ensembl chr 1:221,914,159...222,183,672
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
EXP |
triadimefon results in decreased expression of PKLR mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Plaat1 |
phospholipase A and acyltransferase 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of HRASLS mRNA |
CTD |
PMID:26705709 |
|
NCBI chr11:71,517,492...71,537,142
Ensembl chr11:71,517,493...71,527,020
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
EXP |
triadimefon results in increased expression of PLAT mRNA |
CTD |
PMID:30047161 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
increases expression |
ISO |
triadimefon results in increased expression of PLCG1 mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
decreases expression |
EXP |
triadimefon results in decreased expression of PPAP2B mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Plppr4 |
phospholipid phosphatase related 4 |
decreases expression |
ISO |
triadimefon results in decreased expression of PLPPR4 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 2:205,371,317...205,412,302
Ensembl chr 2:205,371,322...205,412,302
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
affects expression |
ISO |
triadimefon affects the expression of PMAIP1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pnn |
pinin, desmosome associated protein |
decreases expression |
EXP |
triadimefon results in decreased expression of PNN mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
|
|
G |
Pomc |
proopiomelanocortin |
decreases expression |
EXP |
triadimefon results in decreased expression of POMC protein |
CTD |
PMID:34508824 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
EXP |
triadimefon results in increased expression of POR mRNA |
CTD |
PMID:19409404 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Pou6f1 |
POU class 6 homeobox 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of POU6F1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:131,677,719...131,700,869
Ensembl chr 7:131,680,141...131,686,843 Ensembl chr 7:131,680,141...131,686,843
|
|
G |
Ppp1r42 |
protein phosphatase 1, regulatory subunit 42 |
increases expression |
ISO |
triadimefon results in increased expression of PPP1R42 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 5:9,227,109...9,274,461
Ensembl chr 5:9,227,204...9,274,453
|
|
G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
increases expression |
ISO |
triadimefon results in increased expression of PPP2R2B mRNA |
CTD |
PMID:26705709 |
|
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
|
|
G |
Prep |
prolyl endopeptidase |
increases expression |
EXP |
triadimefon results in increased expression of PREP mRNA |
CTD |
PMID:30047161 |
|
NCBI chr20:48,556,211...48,653,165
Ensembl chr20:48,556,280...48,654,466
|
|
G |
Prickle1 |
prickle planar cell polarity protein 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of PRICKLE1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 7:124,639,142...124,735,027
Ensembl chr 7:124,639,142...124,658,113
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
decreases phosphorylation |
EXP |
triadimefon results in decreased phosphorylation of PRKAA1 protein |
CTD |
PMID:36179991 |
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
decreases phosphorylation |
EXP |
triadimefon results in decreased phosphorylation of PRKAA2 protein |
CTD |
PMID:36179991 |
|
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
increases expression |
EXP |
triadimefon results in increased expression of PROC mRNA |
CTD |
PMID:30047161 |
|
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Prodh |
proline dehydrogenase |
decreases expression |
EXP |
triadimefon results in decreased expression of PRODH mRNA |
CTD |
PMID:30047161 |
|
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
|
|
G |
Prpf38b |
pre-mRNA processing factor 38B |
affects expression |
ISO |
triadimefon affects the expression of PRPF38B mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250
|
|
G |
Prss41 |
serine protease 41 |
decreases expression |
EXP |
triadimefon results in decreased expression of PRSS41 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:12,865,872...12,873,552
Ensembl chr10:12,865,872...12,873,552
|
|
G |
Psen1 |
presenilin 1 |
increases expression |
ISO |
triadimefon results in increased expression of PSEN1 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Psip1 |
PC4 and SRSF1 interacting protein 1 |
increases expression |
EXP |
triadimefon results in increased expression of PSIP1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257
|
|
G |
Psmb4 |
proteasome 20S subunit beta 4 |
increases expression |
EXP |
triadimefon results in increased expression of PSMB4 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746
|
|
G |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
increases expression |
ISO |
triadimefon results in increased expression of PSMD11 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
|
|
G |
Psme1 |
proteasome activator subunit 1 |
increases expression |
EXP |
triadimefon results in increased expression of PSME1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
|
|
G |
Ptma |
prothymosin alpha |
increases expression |
EXP |
triadimefon results in increased expression of PTMA mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
increases expression |
EXP |
triadimefon results in increased expression of PTPN1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Ptpru |
protein tyrosine phosphatase, receptor type, U |
decreases expression |
EXP |
triadimefon results in decreased expression of PTPRU mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:143,950,542...144,024,791
Ensembl chr 5:143,950,965...144,024,768
|
|
G |
Ptrh2 |
peptidyl-tRNA hydrolase 2 |
increases expression |
EXP |
triadimefon results in increased expression of PTRH2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
|
|
G |
Pvr |
PVR cell adhesion molecule |
increases expression |
EXP |
triadimefon results in increased expression of PVR mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
|
|
G |
Qars1 |
glutaminyl-tRNA synthetase 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of QARS1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:109,207,705...109,215,738
Ensembl chr 8:109,207,705...109,215,739
|
|
G |
R3hcc1l |
R3H domain and coiled-coil containing 1-like |
decreases expression |
EXP |
triadimefon results in decreased expression of R3HCC1L mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:241,317,199...241,395,240
Ensembl chr 1:241,317,272...241,395,240
|
|
G |
Rab11fip5 |
RAB11 family interacting protein 5 |
increases expression |
EXP |
triadimefon results in increased expression of RAB11FIP5 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:117,871,301...117,908,819
Ensembl chr 4:117,871,308...117,908,741
|
|
G |
Rab14 |
RAB14, member RAS oncogene family |
affects expression |
ISO |
triadimefon affects the expression of RAB14 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:18,501,963...18,523,172
|
|
G |
Rab3b |
RAB3B, member RAS oncogene family |
decreases expression |
ISO |
triadimefon results in decreased expression of RAB3B mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 5:123,629,562...123,697,410
Ensembl chr 5:123,644,423...123,697,401
|
|
G |
Rab9a |
RAB9A, member RAS oncogene family |
decreases expression |
EXP |
triadimefon results in decreased expression of RAB9A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622
|
|
G |
Rac2 |
Rac family small GTPase 2 |
increases expression |
ISO |
triadimefon analog results in increased expression of RAC2 mRNA; triadimefon results in increased expression of RAC2 mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
|
|
G |
Ran |
RAN, member RAS oncogene family |
increases expression |
ISO |
triadimefon results in increased expression of RAN mRNA |
CTD |
PMID:19363144 |
|
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
|
|
G |
Ranbp6 |
RAN binding protein 6 |
increases expression |
EXP |
triadimefon results in increased expression of RANBP6 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:227,572,394...227,576,915
Ensembl chr 1:227,572,105...227,576,942
|
|
G |
Rapgef2 |
Rap guanine nucleotide exchange factor 2 |
increases expression |
EXP |
triadimefon results in increased expression of RAPGEF2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
|
|
G |
Rarb |
retinoic acid receptor, beta |
increases expression |
EXP |
triadimefon results in increased expression of RARB mRNA |
CTD |
PMID:28263823 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rbbp8 |
RB binding protein 8, endonuclease |
increases expression |
ISO |
triadimefon results in increased expression of RBBP8 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
|
|
G |
Rbm24 |
RNA binding motif protein 24 |
decreases expression |
EXP |
triadimefon results in decreased expression of RBM24 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr17:18,275,681...18,288,231
Ensembl chr17:18,275,688...18,288,102
|
|
G |
Rbpjl |
recombination signal binding protein for immunoglobulin kappa J region-like |
decreases expression |
EXP |
triadimefon results in decreased expression of RBPJL mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:153,134,044...153,147,421
Ensembl chr 3:153,134,140...153,146,513
|
|
G |
Rd3 |
RD3 regulator of GUCY2D |
decreases expression |
EXP |
triadimefon results in decreased expression of RD3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr13:103,551,823...103,562,925
Ensembl chr13:103,552,857...103,562,622
|
|
G |
Rfx7 |
regulatory factor X, 7 |
decreases expression |
EXP |
triadimefon results in decreased expression of RFX7 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209
|
|
G |
Rfxank |
regulatory factor X-associated ankyrin-containing protein |
decreases expression |
EXP |
triadimefon results in decreased expression of RFXANK mRNA |
CTD |
PMID:30047161 |
|
NCBI chr16:19,280,857...19,288,886
Ensembl chr16:19,281,475...19,460,255
|
|
G |
Rgcc |
regulator of cell cycle |
decreases expression |
ISO |
triadimefon results in decreased expression of RGCC mRNA |
CTD |
PMID:26705709 |
|
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
|
|
G |
Rgs11 |
regulator of G-protein signaling 11 |
decreases expression |
EXP |
triadimefon results in decreased expression of RGS11 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:15,222,804...15,231,062
Ensembl chr10:15,222,803...15,231,060
|
|
G |
Rgs19 |
regulator of G-protein signaling 19 |
affects expression |
ISO |
triadimefon affects the expression of RGS19 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 3:168,804,532...168,813,035
Ensembl chr 3:168,804,874...168,810,097
|
|
G |
Rhob |
ras homolog family member B |
decreases expression |
ISO |
triadimefon analog results in decreased expression of RHOB mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Rhoc |
ras homolog family member C |
decreases expression |
ISO |
triadimefon analog results in decreased expression of RHOC mRNA; triadimefon results in decreased expression of RHOC mRNA |
CTD |
PMID:26238599 |
|
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
|
|
G |
Rnf144b |
ring finger protein 144B |
decreases expression |
ISO |
triadimefon results in decreased expression of RNF144B mRNA |
CTD |
PMID:26705709 |
|
NCBI chr17:17,431,271...17,580,687
Ensembl chr17:17,432,786...17,562,760
|
|
G |
Rnps1 |
RNA binding protein with serine rich domain 1 |
increases expression |
ISO |
triadimefon results in increased expression of RNPS1 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr10:13,445,516...13,455,858
Ensembl chr10:13,445,653...13,455,858
|
|
G |
Rorb |
RAR-related orphan receptor B |
increases expression |
ISO |
triadimefon results in increased expression of RORB mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:216,363,629...216,544,390
Ensembl chr 1:216,363,629...216,544,390
|
|
G |
Rpl13a |
ribosomal protein L13A |
increases expression |
ISO |
triadimefon results in increased expression of RPL13A mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Rpl34 |
ribosomal protein L34 |
decreases expression |
EXP |
triadimefon results in decreased expression of RPL34 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:219,284,373...219,288,108
Ensembl chr 2:219,284,382...219,288,111
|
|
G |
Rpl38 |
ribosomal protein L38 |
increases expression |
EXP |
triadimefon results in increased expression of RPL38 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:99,701,330...99,705,004
Ensembl chr10:99,701,362...99,705,004 Ensembl chr14:99,701,362...99,705,004 Ensembl chr 3:99,701,362...99,705,004 Ensembl chr 2:99,701,362...99,705,004 Ensembl chr16:99,701,362...99,705,004
|
|
G |
Rpp21 |
ribonuclease P/MRP subunit p21 |
increases expression |
EXP |
triadimefon results in increased expression of RPP21 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr20:2,018,170...2,020,100
Ensembl chr20:2,018,147...2,020,106
|
|
G |
Rps13 |
ribosomal protein S13 |
decreases expression |
EXP |
triadimefon results in decreased expression of RPS13 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:170,572,925...170,575,355
Ensembl chr 1:170,572,921...170,575,355 Ensembl chr 3:170,572,921...170,575,355
|
|
G |
Rps23 |
ribosomal protein S23 |
decreases expression |
EXP |
triadimefon results in decreased expression of RPS23 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:22,079,339...22,080,909
Ensembl chr 2:22,079,302...22,080,918
|
|
G |
Rps25 |
ribosomal protein s25 |
decreases expression |
EXP |
triadimefon results in decreased expression of RPS25 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:44,733,623...44,735,999
Ensembl chr 8:44,733,029...44,737,271
|
|
G |
Rrp7a |
ribosomal RNA processing 7 homolog A |
decreases expression |
EXP |
triadimefon results in decreased expression of RRP7A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:114,262,929...114,272,817
Ensembl chr 7:114,256,472...114,272,817
|
|
G |
Rsrp1 |
arginine and serine rich protein 1 |
affects expression |
ISO |
triadimefon affects the expression of RSRP1 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
|
|
G |
Rundc3a |
RUN domain containing 3A |
decreases expression |
EXP |
triadimefon results in decreased expression of RUNDC3A mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:87,352,624...87,361,767
Ensembl chr10:87,352,646...87,361,765
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
increases expression |
ISO |
triadimefon results in increased expression of S100A8 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
Sap25 |
Sin3A-associated protein 25 |
decreases expression |
EXP |
triadimefon results in decreased expression of SAP25 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr12:19,055,762...19,057,425
Ensembl chr12:19,055,763...19,076,089
|
|
G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of SCD2 mRNA; triadimefon results in decreased expression of SCD2 protein |
CTD |
PMID:36179991 |
|
NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
|
|
G |
Sdc1 |
syndecan 1 |
increases expression |
ISO |
triadimefon results in increased expression of SDC1 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
|
|
G |
Sec61a1 |
SEC61 translocon subunit alpha 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of SEC61A1 mRNA |
CTD |
PMID:16730040 |
|
NCBI chr 4:120,973,519...120,987,871
Ensembl chr 4:120,960,626...120,987,925
|
|
G |
Sec61g |
Sec61 translocon subunit gamma |
increases expression |
EXP |
triadimefon results in increased expression of SEC61G mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:90,899,766...90,906,143
Ensembl chr14:90,899,768...90,906,162
|
|
G |
Sema6d |
semaphorin 6D |
increases expression |
ISO |
triadimefon results in increased expression of SEMA6D mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 3:111,883,415...111,941,100
Ensembl chr 3:111,883,872...111,941,094
|
|
G |
Serpina1 |
serpin family A member 1 |
affects expression |
EXP |
triadimefon affects the expression of SERPINA1 mRNA |
CTD |
PMID:17383973 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serpina9 |
serpin family A member 9 |
decreases expression |
ISO |
triadimefon results in decreased expression of SERPINA9 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr 6:122,918,819...122,936,000
Ensembl chr 6:122,918,880...122,936,000
|
|
G |
Serpine1 |
serpin family E member 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of SERPINE1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
increases expression |
EXP |
triadimefon results in increased expression of SERPINF1 mRNA |
CTD |
PMID:22664269 |
|
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Sf1 |
splicing factor 1 |
increases expression |
ISO |
triadimefon results in increased expression of SF1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:203,670,016...203,683,432
Ensembl chr 1:203,670,018...203,684,330
|
|
G |
Sfpq |
splicing factor proline and glutamine rich |
increases expression |
ISO |
triadimefon results in increased expression of SFPQ mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
|
|
G |
Sfxn2 |
sideroflexin 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of SFXN2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 1:245,447,014...245,459,312
Ensembl chr 1:245,447,015...245,468,411 Ensembl chr 1:245,447,015...245,468,411
|
|
G |
Sh3bgrl3 |
SH3 domain binding glutamate-rich protein like 3 |
increases expression |
EXP |
triadimefon results in increased expression of SH3BGRL3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331
|
|
G |
Sh3yl1 |
SH3 and SYLF domain containing 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of SH3YL1 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:47,522,098...47,565,858
Ensembl chr 6:47,522,091...47,565,858
|
|
G |
Shh |
sonic hedgehog signaling molecule |
decreases expression |
EXP |
triadimefon results in decreased expression of SHH mRNA |
CTD |
PMID:21254369 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Skap2 |
src kinase associated phosphoprotein 2 |
affects expression |
ISO |
triadimefon affects the expression of SKAP2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 4:80,948,832...81,100,900
Ensembl chr 4:80,950,580...81,100,891
|
|
G |
Slbp |
stem-loop histone mRNA binding protein |
decreases expression |
EXP |
triadimefon results in decreased expression of SLBP mRNA |
CTD |
PMID:30047161 |
|
NCBI chr14:77,071,441...77,081,911
Ensembl chr14:77,071,632...77,081,906
|
|
G |
Slc12a5 |
solute carrier family 12 member 5 |
decreases expression |
EXP |
triadimefon results in decreased expression of SLC12A5 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:153,696,517...153,735,801
Ensembl chr 3:153,696,517...153,735,765
|
|
G |
Slc12a6 |
solute carrier family 12, member 6 |
decreases expression |
EXP |
triadimefon results in decreased expression of SLC12A6 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:99,071,577...99,170,266
Ensembl chr 3:99,071,391...99,170,258
|
|
G |
Slc17a2 |
solute carrier family 17, member 2 |
decreases expression |
ISO |
triadimefon results in decreased expression of SLC17A2 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
|
|
G |
Slc1a7 |
solute carrier family 1 member 7 |
decreases expression |
EXP |
triadimefon results in decreased expression of SLC1A7 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:122,731,003...122,775,139
Ensembl chr 5:122,731,003...122,775,134
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
increases expression |
EXP |
triadimefon results in increased expression of SLC22A7 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc25a25 |
solute carrier family 25 member 25 |
increases expression |
EXP |
triadimefon results in increased expression of SLC25A25 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:15,708,703...15,742,216
|
|
G |
Slc25a29 |
solute carrier family 25 member 29 |
increases expression |
EXP |
triadimefon results in increased expression of SLC25A29 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 6:127,742,027...127,752,915
Ensembl chr 6:127,742,033...127,752,940
|
|
G |
Slc2a5 |
solute carrier family 2 member 5 |
decreases expression |
EXP |
triadimefon results in decreased expression of SLC2A5 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
increases expression |
EXP |
triadimefon results in increased expression of SLC3A2 mRNA |
CTD |
PMID:19409404 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc52a2 |
solute carrier family 52 member 2 |
increases expression |
EXP |
triadimefon results in increased expression of SLC52A2 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:108,246,003...108,267,642
Ensembl chr 7:108,262,612...108,268,034
|
|
G |
Slc5a8 |
solute carrier family 5 member 8 |
increases expression |
EXP |
triadimefon results in increased expression of SLC5A8 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 7:23,272,891...23,313,811
Ensembl chr 7:23,272,427...23,314,642
|
|
G |
Slc6a13 |
solute carrier family 6 member 13 |
decreases expression |
EXP |
triadimefon results in decreased expression of SLC6A13 mRNA |
CTD |
PMID:16643972 |
|
NCBI chr 4:154,539,246...154,577,784
Ensembl chr 4:154,540,468...154,576,152
|
|
G |
Slc9a5 |
solute carrier family 9 member A5 |
decreases expression |
EXP |
triadimefon results in decreased expression of SLC9A5 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr19:33,225,481...33,246,913
Ensembl chr19:33,226,816...33,246,903
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
increases expression |
EXP ISO |
triadimefon results in increased expression of SLCO1A4 mRNA |
CTD |
PMID:16643972 PMID:16730040 PMID:19409404 PMID:19423681 PMID:23970803 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Smco4 |
single-pass membrane protein with coiled-coil domains 4 |
increases expression |
EXP |
triadimefon results in increased expression of SMCO4 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:12,313,235...12,365,534
Ensembl chr 8:12,313,328...12,365,529
|
|
G |
Smpd3 |
sphingomyelin phosphodiesterase 3 |
increases expression |
ISO |
triadimefon results in increased expression of SMPD3 mRNA |
CTD |
PMID:23970803 |
|
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
|
|
G |
Snrpg |
small nuclear ribonucleoprotein polypeptide G |
increases expression |
EXP |
triadimefon results in increased expression of SNRPG mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 4:118,812,278...118,819,827
Ensembl chr 4:118,812,252...118,819,826
|
|
G |
Snx24 |
sorting nexin 24 |
decreases expression |
EXP |
triadimefon results in decreased expression of SNX24 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr18:46,670,987...46,826,070
Ensembl chr18:46,671,443...46,826,068
|
|
G |
Snx27 |
sorting nexin 27 |
decreases expression |
EXP |
triadimefon results in decreased expression of SNX27 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 2:182,135,904...182,218,906
Ensembl chr 2:182,135,905...182,218,906
|
|
G |
Snx33 |
sorting nexin 33 |
decreases expression |
EXP |
triadimefon results in decreased expression of SNX33 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 8:57,315,861...57,328,522
Ensembl chr 8:57,317,161...57,327,538
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression |
EXP |
triadimefon results in decreased expression of SOD2 mRNA; triadimefon results in decreased expression of SOD2 protein |
CTD |
PMID:34508824 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sorcs1 |
sortilin-related VPS10 domain containing receptor 1 |
increases expression |
ISO |
triadimefon results in increased expression of SORCS1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:249,080,662...249,594,520
Ensembl chr 1:249,081,355...249,594,507
|
|
G |
Sox13 |
SRY-box transcription factor 13 |
affects expression |
ISO |
triadimefon affects the expression of SOX13 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr13:44,831,097...44,875,522
Ensembl chr13:44,831,085...44,875,762
|
|
G |
Spag6 |
sperm associated antigen 6 |
decreases expression |
EXP |
triadimefon results in decreased expression of SPAG6 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr17:81,352,372...81,401,504
Ensembl chr17:81,349,084...81,401,501
|
|
G |
Spon1 |
spondin 1 |
increases expression |
ISO |
triadimefon results in increased expression of SPON1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
|
|
G |
Sqle |
squalene epoxidase |
affects expression increases expression |
ISO EXP |
triadimefon affects the expression of SQLE mRNA triadimefon results in increased expression of SQLE mRNA |
CTD |
PMID:17178688 PMID:19409404 PMID:19423681 PMID:21195148 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of SRD5A1 mRNA |
CTD |
PMID:19423681 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srsf10 |
serine and arginine rich splicing factor 10 |
increases expression |
EXP |
triadimefon results in increased expression of SRSF10 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768
|
|
G |
Srsf11 |
serine and arginine rich splicing factor 11 |
affects expression |
ISO |
triadimefon affects the expression of SRSF11 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 2:247,074,623...247,101,460
Ensembl chr 2:247,074,631...247,101,425
|
|
G |
Ssr3 |
signal sequence receptor subunit 3 |
increases expression |
ISO |
triadimefon results in increased expression of SSR3 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 2:149,605,005...149,625,069
Ensembl chr 2:149,605,005...149,625,132
|
|
G |
Sstr2 |
somatostatin receptor 2 |
increases expression |
ISO |
triadimefon results in increased expression of SSTR2 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
|
|
G |
Ssu72 |
SSU72 homolog, RNA polymerase II CTD phosphatase |
increases expression |
EXP |
triadimefon results in increased expression of SSU72 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:166,312,267...166,343,432
Ensembl chr 5:166,313,650...166,343,429
|
|
G |
Stag1 |
STAG1 cohesin complex component |
increases expression |
ISO |
triadimefon results in increased expression of STAG1 mRNA |
CTD |
PMID:19363144 |
|
NCBI chr 8:101,179,039...101,564,684
Ensembl chr 8:101,179,039...101,564,677
|
|
G |
Stambpl1 |
STAM binding protein-like 1 |
increases expression |
EXP |
triadimefon results in increased expression of STAMBPL1 mRNA |
CTD |
PMID:28263823 |
|
NCBI chr 1:231,699,620...231,745,034
Ensembl chr 1:231,699,995...231,745,032
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression increases expression |
EXP |
triadimefon results in decreased expression of STAR mRNA; triadimefon results in decreased expression of STAR protein triadimefon results in increased expression of STAR mRNA; triadimefon results in increased expression of STAR protein |
CTD |
PMID:34508824 PMID:36179991 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases expression |
EXP |
triadimefon results in decreased expression of STAT3 protein |
CTD |
PMID:36179991 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
decreases expression decreases activity |
ISO |
triadimefon results in decreased expression of STAT5B mRNA triadimefon results in decreased activity of STAT5B protein |
CTD |
PMID:19363144 PMID:30114225 |
|
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Sulf1 |
sulfatase 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of SULF1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 5:6,362,894...6,526,174
Ensembl chr 5:6,362,911...6,525,584
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
decreases expression |
ISO |
triadimefon results in decreased expression of SULT1E1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Sync |
syncoilin, intermediate filament protein |
decreases expression |
ISO |
triadimefon results in decreased expression of SYNC mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 5:141,631,837...141,656,184
Ensembl chr 5:141,632,367...141,688,659
|
|
G |
Tac1 |
tachykinin, precursor 1 |
increases expression |
ISO |
triadimefon results in increased expression of TAC1 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tagln |
transgelin |
decreases expression |
ISO |
triadimefon results in decreased expression of TAGLN mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tax1bp3 |
Tax1 binding protein 3 |
increases expression |
EXP |
triadimefon results in increased expression of TAX1BP3 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
|
|
G |
Tcf24 |
transcription factor 24 |
increases expression |
ISO |
triadimefon results in increased expression of TCF24 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 5:9,274,659...9,282,876
Ensembl chr 5:9,227,131...9,279,636
|
|
G |
Tdrd7 |
tudor domain containing 7 |
increases expression |
EXP |
triadimefon results in increased expression of TDRD7 mRNA |
CTD |
PMID:30047161 |
|
NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544
|
|
G |
Tfap2c |
transcription factor AP-2 gamma |
affects expression |
ISO |
triadimefon affects the expression of TFAP2C mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 3:161,315,114...161,322,998
Ensembl chr 3:161,315,031...161,322,995
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of TGFB1 mRNA; triadimefon results in decreased expression of TGFB1 protein |
CTD |
PMID:18976680 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
decreases expression |
EXP ISO |
triadimefon results in decreased expression of TGFB2 mRNA |
CTD |
PMID:18976680 PMID:26705709 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
decreases expression |
EXP |
triadimefon results in decreased expression of TGFBR1 mRNA |
CTD |
PMID:18976680 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Thap11 |
THAP domain containing 11 |
affects expression |
ISO |
triadimefon affects the expression of THAP11 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr19:33,746,977...33,748,794
Ensembl chr19:33,746,854...33,749,540
|
|
G |
Thbs2 |
thrombospondin 2 |
affects expression |
ISO |
triadimefon affects the expression of THBS2 mRNA |
CTD |
PMID:21195148 |
|
NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
decreases expression |
ISO |
triadimefon results in decreased expression of TIMP4 mRNA |
CTD |
PMID:26705709 |
|
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
|
|
G |
|